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Although natural killer (NK) cells are considered part of the innate immune system, 
recent studies have demonstrated the capability of virus-specific NK cells to become 
long-lived and contribute to potent recall responses similar to T and B cells. The 
precise signals that promote the generation of a long-lived NK cell response are 
largely undefined. This dissertation investigates the role of pro-inflammatory 
cytokines interleukin (IL)-12, IL-18, and type I IFN on the NK cell response during 
mouse cytomegalovirus (MCMV) infection. We demonstrate that IL-12 and its 
signaling component STAT4 are indispensible for MCMV-specific NK cell expansion 
and generation of “memory” NK cells in lymphoid and non-lymphoid tissues. 
Furthermore, IL-12 and STAT4 signaling in activated NK cells increased the 
expression of the adaptor protein MyD88, which mediates signaling downstream of 
the IL-18 receptor, and T-box transcription factor T-bet. During MCMV infection, NK 
cells required IL-18 receptor and MyD88 for optimal primary expansion, but not recall 
responses. In addition, NK cell-specific deletion of T-bet or Eomes crippled the anti-
viral NK cell response. Lastly, we show type I IFN and STAT1 signaling protects NK 
cells form NKG2D-mediated killing, thus promoting a robust antiviral NK cell 
 response. This work highlights the complex, non-redundant, and stage-specific role of 
pro-inflammatory cytokines and transcription factors on the NK cell response.  
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CHAPTER 1 
INTRODUCTION 
NK cells: Bridging the gap between innate and adaptive immunity 
The immune system is traditionally compartmentalized into two distinct arms of 
immunity, the innate arm and the adaptive arm, which together aid in the efficient 
execution of anti-pathogen and anti-tumor responses. The innate immune system 
constitutes the earliest defense against pathogen invasion and is typically described 
as mediating swift, but non-specific and short-lived immune responses. Conversely, 
the adaptive immune system provides a delayed but antigen-specific response, and 
is capable of immunological memory, a quality that has become a defining feature 
of adaptive immunity. Historically, T and B cells, which possess antigen-specific 
receptors that result from somatic gene rearrangement, have been the sole members 
of the adaptive immune system, classifying all other immune cells as part of the 
innate immune system. Despite being a vital member of the innate immune system, 
recent findings have revealed that NK cells fail to adhere to the traditional innate-
adaptive dichotomy and exhibit many “adaptive” features, including immunological 
memory and a heightened effector response upon antigen re-encounter.  
 
NK cell characteristics and function 
NK cells are traditionally classified as innate immune cells. Initially postulated to 
reject cells that have downregulated MHC I due to viral infection or transformation 
(termed the “missing self” hypothesis (1)), NK cells are now appreciated to form a 
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vital component of the anti-viral and anti-tumor immune response. NK cells are 
derived from the same lymphocyte progenitor as T and B cells (2), and resemble 
CD8+ T cells in phenotype and function. Despite these commonalities, NK cells 
differ from T and B cells in that their function does not rely on RAG-mediated 
rearrangement of antigen receptors. Instead, NK cells express a combination of 
germ-line encoded receptors that provide inhibitory and activating signals, which 
ultimately dictate the activation status of the cell. Once activated, NK cells are able 
to lyse target cells through the exocytosis of perforin- and granzyme-containing 
granules, and to secrete cytokines, such as IFN-γ, TNF-α, and GM-CSF, which alert 
and influence the broader immune response. Until recently, scientists have 
considered these NK cell responses to be short-lived, antigen-non-specific, and 
qualitatively similar during primary or subsequent challenges with a specific 
pathogen. However, recent studies have ascribed a broader range of new 
immunological capabilities to NK cells, including the ability to execute a long-lived 
antigen specific response, or “memory” response – a feature previously thought only 
to exist in B and T cells. NK cell “memory” responses have been demonstrated in 
the context of challenge with haptens, pro-inflammatory cytokines, and certain 
viruses, and the cellular and molecular events that control these responses are an 
area of active investigation in the field (3). 
Cytomegalovirus (CMV) infection results in an anti-viral NK cell response 
in both human and mice. A member of the beta subfamily of Herpesviridae, CMV is 
a large double-stranded DNA virus that is thought to have co-evolved with its 
mammalian host species. This virus-host co-evolution is exemplified by the 
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numerous viral homologues of MHC I proteins encoded by mouse CMV (MCMV) 
and human CMV (HCMV), which allow the virus to evade host immune cells (4). 
The importance of NK cells in the control of CMV is highlighted by various reports 
of increased susceptibility to CMV infection in mice and humans lacking functional 
NK cells (5-7). Furthermore, studying the NK cell response against MCMV has 
proven to be a useful model for further understanding HCMV infection in humans, 
due to the high similarity in pathogenicity of the two viruses and the similarities in 
clinical manifestation of disease (8).  
MCMV was the first pathogen described to elicit an antigen-specific NK cell 
response.  Following MCMV infection of C57BL/6 mice, the viral antigen m157 is 
expressed on the surface of infected cells, and causes the robust expansion of NK 
cells bearing the activating Ly49H receptor (9, 10), which signals through the 
DAP12 adaptor protein (11) (Figure 1.1).  Ly49H+ NK cells undergo a clonal-like 
expansion phase that peaks at day 7 post-infection (PI) (9). This “clonal”-like 
expansion phase is followed by a Bim-mediated contraction phase that results in a 
population of long-lived memory NK cells (12). Memory Ly49H+ NK cells have 
been shown to mediate a more protective anti-viral response upon secondary 
challenge with MCMV (13). Long-lived NK cell responses have also been reported 
in humans during viral infection. Human studies have identified an enrichment of 
NK cells bearing the germline-encoded NKG2C receptor in patients with acute 
HCMV infection (14-16).  Furthermore, HCMV reactivation in patients undergoing  
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Figure 1.1 
 
Figure 1.1. The NK cell response against MCMV.  A subset of natural killer cells in 
the C57BL/6 mouse express the activating receptor Ly49H, which recognizes MCMV-
encoded glycoprotein m157. Antigen receptor engagement, along with MCMV-
induced pro-inflammatory cytokines, leads to the potent activation of the NK cell, 
which promotes cytokine production (IFN-γ), cell-mediated toxicity (perforin and 
granzymes), and the clonal-like proliferation of Ly49H-bearing NK cells. Virally 
expanded antigen specific NK cells undergo a contraction phase that leaves behind a 
pool of long-lived “memory” NK cells, which have heightened protective capabilities 
upon secondary pathogen encounter.  
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hematopoietic stem cell transplantation resulted in a long-lived population of 
NKG2C+ NK cells that were potent IFN-γ producers (17).   
The capability of an NK cell to control viral infections and to kill a 
susceptible target cell without prior sensitization has made this cell an attractive 
target in vaccine strategies and anti-tumor immunotherapy. NK cells help mediate 
the protective effect of certain DC-based vaccines (18). NK cell adoptive 
immunotherapy has also found success. NK cells have been shown to decrease 
graft-versus-host-disease (GVHD) and facilitate engraftment in patients receiving 
hematopoietic stem cell transplant (HSCT) (19). Moreover, post-transplant infusion 
of NK cells in AML patients reduced leukemia progression and increased overall 
survival (20). Although the potential benefits of NK cells in vaccination and 
immunotherapy have become evident, further knowledge of how to activate and 
harness NK cell function will prove a key step in the successful use of NK cells in 
the clinic.  
 
Pro- inflammatory cytokines: A critical influence on NK cell function 
NK cell development, homeostasis, and function are directly influenced by 
cytokines.  During infection, the pro-inflammatory cytokines, IL-12, IL-18, and type 
I IFNs are of interest in NK cells for several reasons. First, resting NK cells 
constitutively express the appropriate receptors to sense these cytokines. Second, 
pro-inflammatory cytokines may provide a crucial signal in antigen-dependent NK 
cell activation. CD8+ T cells require 3 signals for a productive and protective 
antigen-specific response (Figure 1.2). “Signal 1” is provided through the triggering  
  6 
 
Ly49H&
CD28&
IL,12&
IL,18&
IFNα&
m157 
CD8+%T%cell%
TCR&
CD28&
IL,12&
IFNα&
%
% %
%
MCMV 
Natural%killer%cell%
Dendri3c%cell%
(1)&
(2)&
(3)&
(1)&
(2?)&
(3)&
Full effector function 
Memory formation  
Figure 2 
 
Figure 1.2. Necessary signals for optimal anti-viral responses in NK and CD8+ T 
cells. Viral infection activates NK and CD8+ T cells, which mount a specific response 
following the triggering of antigen receptors. The proper activation, expansion, and 
differentiation of CD8+ T cells depends on three important signals: (1) antigen-
mediated TCR engagement, (2) costimulation, and (3) cytokine signaling, like that 
provided by IL-12 or type I interferon. NK cells also rely on antigen stimulation and 
pro-inflammatory cytokine signaling for the development of full effector function and 
memory formation. Unpublished observations by Sun et al. suggest costimulation 
through CD28 is also necessary for optimal NK cell activation.  
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TCR by MHC class I plus peptide (21). Virus-specific NK cells receive a similar 
signal through the interaction of Ly49H with viral m157. “Signal 2” in T cells 
comes in the form of co-stimulation through the engagement of CD28 (21). 
Unpublished observations from our lab suggest CD28 is also important during NK 
cell activation. Lastly, a productive and long-lasting antigen-specific CD8+ T cell 
response requires “Signal 3”, provided by pro-inflammatory cytokines IL-12 and 
type I IFN (22). “Signal 3” is also able to affect the gene expression landscape by 
regulating the expression of key transcription factors involved in cellular 
differentiation. More specifically, IL-12 modulates the expression of T-box 
transcription factors, T-bet and Eomes, which influence effector and memory CD8+ 
T cell differentiation following pathogen infection (23, 24). IL-12, IL-18, and type I 
IFN are known to strongly impact the early anti-viral NK cell response (discussed 
below). Moreover, T-box transcription factors, T-bet and Eomes, are known to 
affect NK cell development and maturation; however, their effect on the mature NK 
cell anti-viral response is unclear. The potential effects on the long-lived antigen-
specific NK cell response by “Signal 3” cytokines and the transcription factors they 
help modulate, have not been previously addressed.  
Ex vivo cytokine treatment was recently shown to activate naïve NK cells, 
endowing them with enhanced effector functions and a prolonged lifespan, 
reminiscent of memory (25). Resting mouse NK cells treated with an IL-12, IL-18, 
and IL-15 cytokine cocktail persisted for weeks following-transfer into lymphopenic 
hosts. Moreover, these cytokine-treated NK cells produced more IFN-γ following 
re-stimulation than their untreated counterparts (25) – much like memory NK cells 
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generated during infection -  and were shown to be more protective than untreated 
NK cells against established mouse tumors (26). Similarly, human NK cells 
stimulated with exogenous pro-inflammatory cytokines also exhibit enhanced IFN-γ 
production upon re-stimulation (27). The mechanism of cytokine-induced NK cell 
memory is still unknown, but may involve heritable epigenetic repatterning induced 
by pro-inflammatory cytokine treatment. 
Several studies have explored the role of pro-inflammatory cytokines on the 
anti-viral NK cell response (28-31). Direct infection of cytokine- or cytokine 
receptor-deficient mice revealed a non-redundant role for IL-12 and IL-18 on NK 
cell production of IFN-γ following MCMV infection (30, 31). Other studies have 
suggested IL-18, but not IL-12, influences NK cell proliferation after viral infection 
(32). However, in light of the global effects of IL-12, IL-18, and type I IFN on the 
broader immune system, a more refined experimental system must be employed to 
address the direct effect of cytokine signaling on NK cells during viral infection. In 
addition, the specific role of pro-inflammatory cytokine signaling on the generation 
of memory NK cells in the context of viral infection has yet to be explored.  
 
IL-12 
IL-12 is a potent immunomodulatory cytokine that promotes cell-mediated 
immunity. IL-12 signals through a heterodimeric receptor composed of two chains: 
IL-12Rβ1 and IL-12Rβ2 (Figure 1.3). Engagement of the IL-12Rβ1/IL-12Rβ2 
receptor by IL-12 leads to the activation of Janus family kinases, Tyrosine kinase 2 
(Tyk2) and Janus kinase 2 (Jak2) (33), which in turn activate the transcription  
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Figure 3 
Figure 1.3. IL-12, IL-18, and type I IFN signaling pathways. Triggering of the IL-
12 receptor by IL-12 leads to the recruitment and activation of Janus family kinases, 
Tyrosine kinase 2 (Tyk2) and Janus kinase 2 (Jak2). Once activated, Tyk2 and Jak2 
primarily activate STAT4. Activation of STAT4 leads to the formation of a 
homodimer that translocates into the nucleus and affects gene transcription. Upon 
binding of IL-18, the IL-18 receptor recruits MyD88. MyD88 triggers a signaling 
pathway that leads to the activation of NFκB and MAPK. NFκB and MAPK are able 
to translocate into the nucleus and affect gene transcription. Triggering through the 
type I IFN receptor leads to the phosphorylation and activation of STAT1 and STAT2. 
Activation of the STAT proteins leads to the formation of STAT1 homodimers and 
STAT1/2 heterodimers that translocate to the nucleus and affect gene transcription.  
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factor, signal transducer and activation of transcription 4 (STAT4) (34), among 
others. Activation-induced phosphorylation of STAT4 causes its homodimerization 
and translocation into the nucleus, where it acts to regulate gene transcription (35).  
IL-12 is produced early after viral infection (29-31) by antigen-presenting 
cells (APCs) like macrophages (36) and dendritic cells (37), and has wide reaching 
effects on hematopoietic cells, in particular lymphocytes. For example, IL-12 is 
known to promote the differentiation of naive CD4+ T cells into T-helper (Th) 1 
cells (38), the activation of NK and CD8+ T cells, and B cell proliferation and 
differentiation (39). Furthermore, IL-12 shapes pathogen-induced CD8+ T cell 
differentiation through the inverse regulation of T-box transcription factors, T-bet 
and Eomes (23). In NK cells, IL-12 is best known for its ability to strongly induce 
IFN-γ production following viral infection (40), a task it completes with help of IL-
18 (41).    
 
IL-18 
IL-18 is a member of the IL-1 family of cytokines. It is produced as a pro-cytokine 
that is cleaved by inflammasome-activated caspase-1 into its biologically active 
form (42). IL-18 signals through a heterodimeric receptor composed of two chains: 
IL-18R1 and IL-18RAP (Figure 1.3). Unlike most other hematopoietic cells, NK 
cells express very high levels of both receptor chains at rest. Upon binding of IL-18, 
the heterodimeric receptor recruits myeloid differentiation primary response 88 
(MyD88) protein, which in turn directs the activation of the NFκB and MAPK 
signaling pathways. Numerous cells, including dendritic cells (43), macrophages 
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(44), neutrophils (45), and non-hematopoietic cells (46, 47) produce IL-18. IL-18 is 
thought to provide resting NK cells with a “priming” signal that renders them 
responsive to IL-12 stimulation (48), and has been suggested to influence NK cell 
migratory function (49). In collaboration with IL-12, IL-18 stimulates NK, CD8+ T, 
Th1 and B cells to secrete IFN-γ. However, IL-18 alone or in conjunction with IL-4 
and IL-13 can stimulate Th2 cytokines and contribute to allergic inflammation (50-
52).  
 
Type I IFN 
The type I IFN cytokine family is composed of several IFN-alpha subtypes and one 
IFN-beta subtype in humans and mice, among others (53). Type I IFN family 
cytokines signal through a ubiquitously expressed heterodimeric receptor comprised 
of two chains: IFNAR1 and IFNAR2 (Figure 1.3). Triggering through the type I 
IFN receptor leads to the phosphorylation and activation of STAT1 and STAT2, and 
the subsequent formation of STAT1 homodimers and STAT1/2 heterodimers that 
translocate to the nucleus and regulate gene transcription. Immune and non-immune 
cells alike produce and sense type I IFNs. Type I IFNs are able to act directly on NK 
cells to promote their activation and cytotoxic function during viral infection (40, 
54-56). Type I IFNs were initially suggested to induce the proliferation of NK cells 
during MCMV infection (29). This effect, however, was not a consequence of direct 
signaling on NK cells, but rather a result of type I IFN induction of IL-15 (57).  
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T-box Transcription Factors  
T-box family transcription factors Eomes and T-bet have wide-ranging effects that 
direct lymphocyte immunity. The role of T-bet and Eomes in the response of CD8+ 
T cells against pathogens has been well characterized (58, 59). Recent studies have 
highlighted the importance of Eomes and T-bet in NK cell development and 
function (58, 60-62). Similar to effector and memory CD8+ T cells, mature NK cells 
exhibit constitutive T-bet and Eomes expression (60, 63).  T-bet and Eomes have 
been described to control specific checkpoints of NK cell development and 
maturation, with expression of DX5, loss of TRAIL, and gain of Ly49 receptor 
diversity (all characteristics of NK cell maturation) being dependent on Eomes (61). 
In the liver, T-bet was shown to control the development of a distinct Eomes- NK 
cell lineage (62). The role of these transcription factors on the antiviral response of 
mature NK cells has not been studied.  
The work presented in this thesis seeks to explore the cell-intrinsic role of 
the pro-inflammatory cytokines, IL-12, IL-18, and Type I IFNs, and T-box 
transcription factors, T-bet and Eomes, on the early and long-lived NK cell response 
against MCMV. In contrast to previous reports, the studies described herein utilize 
experimental systems that eliminate or decrease pleiotropic effects of cytokine 
signaling, by employing NK cell-specific deletion of the IL-12, IL-18, or type I IFN 
cytokine receptors; additionally, this works employs an inducible gene deletion 
system to elucidate the role of T-bet and Eomes in mature NK cells during the 
course of MCMV infection. 
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Introduction 
The generation of a productive NK cell response is crucial to protect the host from 
viral infection.  In the absence of NK cells or NK cell function, both mice and 
humans are susceptible to a number of pathogens, particularly members of the 
herpesvirus family (64).  Accumulating evidence in mice and humans suggests that 
like the cells of adaptive immunity, NK cells can “remember” previously 
encountered pathogens through the generation of long-lived memory cells following 
initial antigen exposure (65-67).  During MCMV infection, Ly49H-bearing NK cells 
undergo a robust clonal-like expansion (13, 68) and persist in both lymphoid and 
non-lymphoid organs for several months (13).  During a second or third encounter 
with the same virus, these long-lived memory NK cells are capable of prolific recall 
responses, mediating greater effector function and protection than naïve resting NK 
cells (25, 69).  Similar robust NK cell clonal-like expansion and memory has been 
observed during acute hantavirus and HCMV infection in humans, where recent 
longitudinal studies revealed virus-specific responses in the NKG2C-bearing NK 
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cell subset (14, 70).  The goal of immunization is to provide protection against 
subsequent infection, and thus it is vital to define the precise signals that promote 
the generation of NK cell memory. 
 
Pro-inflammatory cytokines such as IL-12 are known to globally promote NK and T 
cell activation and cytotoxicity.  Binding of IL-12 to a two chain receptor composed 
of IL-12 receptor (IL-12R) β1 and β2 results in a signaling cascade leading to 
phosphorylation and dimerization of STAT4, which translocates to the nucleus and 
activates downstream targets and transcription of effector cytokine genes such as 
IFN-γ (71).  Early studies involving cytokine or neutralizing antibody treatment of 
mice demonstrated that IL-12 has global effects on the immune system, as many 
hematopoietically derived cells express the IL-12R (71).  During infection, IL-12 is 
primarily produced by dendritic cells, and can act on many cell types including B 
cells, T cells, NK cells, NK T cells, and even other dendritic cells and hematopoietic 
progenitor cells (71). Studies comparing the response of NK cells that can or cannot 
sense IL-12, in a setting where pleiotrophic effects are reduced or eliminated, have 
not been done. Furthermore, long-lived memory NK cell generation in the absence 
of IL-12 signaling was not previously investigated. Using mice deficient in the IL-
12 receptor and STAT4, and a recently developed adoptive transfer system (13), we 
were uniquely able to investigate the direct in vivo role of IL-12 signaling in NK 
cells during MCMV infection, in the absence of any indirect effects.  
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Results and Discussion 
Similar phenotype and function of wildtype and Il12rb2-/- NK cells at steady-state 
IL-12 is not required for NK cell development or homeostasis during steady-state 
(i.e. the absence of inflammation, infection, or lymphopenia), as normal NK cell 
numbers are found in IL-12- and IL-12R-deficient mice (72-75).  In accordance 
with prior studies, Il12rb2-/- mice contained similar percentages of T, B, NK, and 
NK T cell populations when compared with wildtype mice (Figure 2.1A, and data 
not shown). Within the NK cell compartment, WT and Il12rb2-/- mice had similar 
percentages of Ly49D- and Ly49H-expressing cell subsets (Figure 2.1A). 
Furthermore, Il12rb2-/- NK cells exhibited a phenotype similar to WT NK cells as 
determined by CD27, CD11b, KLRG1, and CD69 expression (Figure 2.1A). In the 
absence of infection, WT and Il12rb2-/- mice cleared β2m-deficient target cells 
equally well (Figure 2.1B), suggesting that Il12rb2-/- NK cells exhibited normal in 
vivo cytotoxic function. When activating NK cell receptors were triggered with 
plate-bound antibodies, Il12rb2-/- NK cells were able to degranulate similar to WT 
NK cells (Figure 2.1C).  Lastly, Il12rb2-/- NK cells were able to kill m157-bearing 
target cells as well as WT NK cells ex vivo (Figure 2.1D), demonstrating that 
Ly49H-mediated cytotoxicity is not dependent upon IL-12 signaling at steady state. 
Defective expansion of Il12rb2-/- NK cells during MCMV infection 
Previous studies examined the role of IL-12 on NK cells by one of three methods: 
injecting the IL-12 cytokine directly, blocking IL-12 with neutralizing antibodies, or 
infecting cytokine-deficient mice (29, 72-76). In each of these experimental 
  16 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1. NK cells from IL-12 receptor-deficient mice are phenotypically and 
functionally similar to NK cells from WT mice.  (A) Percentages of TCR-β- NK1.1+ 
NK, TCR-β+ NK1.1+ NKT, and TCR-β+ NK1.1- T cell populations are shown for 
uninfected WT and Il12rb2-/- mice (left plot). The right plots are gated on TCR-β- 
NK1.1+ cells and analyzed for expression of Ly49D, Ly49H, CD27, CD11b, KLRG1, 
and CD69. (B) Wildtype and B2m-/- splenocytes were labeled with low or high 
concentrations of CFSE, respectively, and co-injected into WT or Il12rb2-/- mice. 
Transferred cells were analyzed in spleen of recipient mice 72 hours after injection. 
(C) NK cells from WT or Il12rb2-/- mice were stimulated with plate-bound antibodies 
against NK1.1 and Ly49H, or with PMA and ionomycin. Uncoated wells (containing 
no Abs) served as negative control and background staining. Percentages of TCR-β- 
NK1.1+ cells expressing CD107 (LAMP-1) are shown for each condition. Error bars 
show s.e.m. (n = 2–3 for each condition). (D) Varying numbers of NK cells from WT, 
Il12rb2-/-, or Ly49h-/- mice were incubated with Ba/F3 and Ba/F3-m157 target cells 
labeled with 51Cr. Percentage killing was calculated based on release of 51Cr into 
supernatant by lysed target cells. All data are representative of at least 3 independent 
experiments. 
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systems, uncontrolled global effects are expected due to the expression of the IL-12 
receptor on many immune cell populations. Infection of IL-12-deficient mice results 
in higher viral titers (compared to wildtype mice) in many instances (72). To 
circumvent this problem, we generated mixed bone marrow chimeric mice, where 
approximately half of the hematopoietic compartment expressed the IL-12Rβ2 and 
the other half was deficient. Reconstitution of all immune cell populations was 
found to be equally distributed between WT and Il12rb2-/-, including the NK cell 
compartment (Figure 2.2A, and data not shown).  
Following MCMV infection of mixed chimeric mice, WT NK cells 
preferentially expanded over 7 days and became the predominant NK cell subset in 
the spleen (Figure 2.2A). A roughly 5-fold increase in total numbers of WT 
compared to Il12rb2-/- NK cells was observed at day 7 post-infection (PI) (Figure 
2.2B). A similar outcome was observed in non-lymphoid organs such as the liver 
(data not shown). The expansion of the WT NK cell compartment was due to the 
rapid proliferation of Ly49H-bearing cells (Figure 2.2C). Although the uninfected 
chimeric mice contained similar numbers of WT and Il12rb2-/- Ly49H+ NK cells, by 
seven days PI the wildtype Ly49H+ NK cells were nearly 10-fold higher in absolute 
number compared to Il12rb2-/- Ly49H+ NK cells (Figure 2.2D). Consistent with a 
role for IL-12 in IFN-γ induction, fewer Il12rb2-/- NK cells produced IFN-γ 
compared with WT NK cells at day 1.5 PI, and the Il12rb2-/- NK cells made less 
IFN-γ per cell (as measured by mean fluorescence intensity). Interestingly, WT and 
Il12rb2-/- NK cells similarly upregulated the activation marker CD69 (Figure 2.2E). 
Induction of CD69 expression correlates with type I IFN-mediated activation, and  
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Figure 2.2. IL-12R-deficient NK cells exhibit defective proliferation during 
MCMV infection.  (A) Mixed bone marrow chimeric mice were infected with 
MCMV and percentages of splenic WT (CD45.1+) and Il12rb2-/- (CD45.2+) NK cells 
are shown (gated on CD3- NK1.1+) in uninfected mice and various time points post-
infection. (B) The absolute numbers of splenic WT and Il12rb2-/- NK cells on day 0 
and 7 PI are graphed. (C) Percentages of Ly49H+ cells within the WT and Il12rb2-/- 
NK cell population (TCR-β- NK1.1+) are shown for uninfected mice and various time 
points post-infection. (D) The absolute numbers of WT and Il12rb2-/- Ly49H+ NK 
cells on day 0 and 7 PI are graphed. (E) Expression of CD69, production of IFN-γ, and 
phosphorylation of STAT4 are shown for WT and Il12rb2-/- NK cells (compared to 
uninfected mice) at day 1.5 PI. (F) Expression of KLRG1, CD27, CD90 (Thy-1), 
Ly6C, and Ki67 on WT and Il12rb2-/- Ly49H+ NK cells (compared to uninfected 
mice) at day 7 PI. (G) WT or Il12rb2-/- NK cells (CD45.2+) were labeled with 5 µM 
CFSE and transferred into Ly49H-deficient hosts (CD45.1+). Following MCMV 
infection, dividing NK cells were analyzed at day 4 and 6 PI (compared to uninfected 
control mice). (H) Adoptively transferred WT and Il12rb2-/- NK cells were stained for 
Annexin V at day 0 and 4 PI. Percentage of Ly49H+ and Ly49H- NK cells positive for 
Annexin V are shown. Error bars for all graphs show s.e.m. (n = 3–5 for each time 
point) and all data are representative of 5 independent experiments.  
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our current data supports a mechanism whereby IFN-γ secretion and CD69 
expression result from two segregated signaling pathways even though both are 
determinants of activation status. Phosphorylation of the signaling component 
STAT4 has been shown to be a consequence of IL-12R signaling leading to IFN-γ 
induction (71); thus, we examined splenic NK cells for phosphorylation of STAT4 
early after infection. Whereas robust phosphorylation of STAT4 was observed in 
nearly all WT NK cells on day 1.5 PI, Il12rb2-/- NK cells showed minimal levels of 
phosphorylated STAT4 (Figure 2.2E). Nearly half of the Il12rb2-/- NK cells 
remained unphosphorylated for STAT4, at levels comparable to uninfected WT and 
Il12rb2-/- mice (Figure 2.2E). Splenic T cells from the same infected mice showed 
minimal amounts of STAT4 phosphorylation in both WT and Il12rb2-/- mice (data 
not shown), consistent with previous findings that NK cells are the early and major 
producers of IFN-γ during infection (77). At day 7 PI, WT Ly49H+ NK cells 
strongly upregulated KLRG1, Ly6C, CD90 (Thy-1), and Ki67 (a nuclear marker of 
cellular proliferation), and downregulated CD27, in contrast to Il12rb2-/- Ly49H+ 
NK cells (Figure 2.2F), suggesting that IL-12 signals during MCMV infection are 
crucial towards achieving a full maturation program in virus-specific NK cells.  
 We determined whether the Il12rb2-/- NK cells were expanding as 
extensively as WT NK cells, or were dying faster once activated. Adoptive transfer 
of carboxyfluorescein succinimidyl ester (CFSE)-labeled WT or Il12rb2-/- NK cells 
into Ly49H-deficient mice confirmed that both WT and Il12rb2-/- NK cells 
proliferated after infection, with the WT NK cells dividing more extensively (Figure 
2.2G). By day 6 PI, the WT NK cells had fully diluted their CFSE, whereas the 
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Il12rb2-/- NK cells remained intermediate for CFSE staining (Figure 2.2G); these 
results corroborate the higher expression of Ki67 detected on WT compared to 
Il12rb2-/- NK cells at day 7 PI (Figure 2.2F). At day 4 PI, WT and Il12rb2-/- NK 
cells showed comparable staining for Annexin V (Figure 2.2H), suggesting that a 
lack of IL-12 signal does not result in greater apoptosis. 
 
IL-12 signals required for memory NK cell generation and protection during 
MCMV infection 
A recent study demonstrated that although defective IL-12 signaling in CD8+ T cells 
also resulted in fewer effector cells, surprisingly higher numbers of memory cells 
were generated (78).  Therefore, we investigated the long-term consequences of IL-
12 signaling during the NK cell response against MCMV infection. Using a 
previously described adoptive transfer system (13), we purified NK cells from WT 
and Il12rb2-/- mice and transferred an equal number of Ly49H+ NK cells from each 
group into separate DAP12-deficient hosts, which are deficient in Ly49H-
expressing NK cells. Following MCMV infection, we found that WT NK cells 
proliferated robustly in the new hosts, in contrast to Il12rb2-/- NK cells (Figure 
2.3A). The percentage and absolute number of WT Ly49H+ NK cells at day 7 PI 
were 15- to 20-fold higher than the Il12rb2-/- NK cells (Fig. 2.3a and b). Strikingly, 
whereas WT NK cells were easily recovered from recipient mice several weeks 
later, adoptively transferred Il12rb2-/- NK cells were not detectable after week 2 PI 
(Figure 2.3B). Co-adoptive transfer of equal numbers of WT and Il12rb2-/- NK cells 
into recipient mice yielded the same outcome following infection, with WT NK  
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Figure 2.3. NK cells from Il12rb2-/- mice fail to become long-lived memory cells 
and mediate protection following MCMV infection.  (A-B) A total of 1x105 WT or 
Il12rb2-/- Ly49H+ NK cells (both CD45.2+) were transferred into DAP12-deficient 
mice (CD45.1+) and infected with MCMV. (A) Plots are gated on total NK cells and 
percentages of adoptively transferred CD45.2+ Ly49H+ NK cells are shown for each 
time point PI. (B) Absolute number of adoptively transferred WT and Il12rb2-/- 
Ly49H+ NK cells in the spleen of recipient mice are shown. Error bars show s.e.m. (n 
= 3–5). ND, not detectable (or below the limits of detection). (C) WT (CD45.1+) and 
Il12rb2-/- (CD45.2+) Ly49H+ NK cells were co-adoptively transferred into Ly49H-
deficient mice and infected with MCMV. Plots are gated on transferred NK cells and 
percentages of WT and Il12rb2-/- NK cells are shown for spleen and liver at day 0, 7, 
and 50 PI.  All data are representative of five experiments with 3-5 mice per time 
point.  (D) WT (CD45.1+) and Il12rb2-/- (CD45.2+) mice were infected with MCMV 
and splenic Ly49H+ NK cells on day 7 PI were purified, mixed at a 1:1 ratio, and co-
transferred into Ly49H-deficient mice. Plots are gated on transferred NK cells and 
percentages of WT and Il12rb2-/- NK cells are shown for at various time points PI and 
post-transfer (PT).  All data are representative of three experiments with 2-4 mice per 
time point. The graph shows the percentage of adoptively transferred WT and Il12rb2-
/- Ly49H+ NK cells within the total NK cell population, and error bars show s.e.m. (n = 
3–4). (E) DAP12-deficient neonatal mice received 1x105 WT or Il12rb2-/- NK cells (or 
PBS as control) followed by MCMV infection. The graph shows the percentage of 
surviving mice for each group, and data were pooled from three experiments.  
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cells preferentially expanding at day 7 PI to become the only memory NK cells 
detected months later in both spleen and liver (Figure 2.3C). To determine whether 
fewer Il12rb2-/- NK cells were recovered at later time point simply because they 
could not expand as well, equal numbers of WT and Il12rb2-/- effector Ly49H+ NK 
cells isolated at day 7 PI  (1:1 mix) were adoptively transferred and memory cell 
percentages determined at later time points (Figure 2.3D). Although the day 7 
effector NK cell numbers were experimentally normalized, only WT NK cells were 
detected one month later in recipient mice (Figure 2.3D). Thus, IL-12 signals are 
crucial not only for the optimal expansion of virus-specific NK cells during 
infection, but also for the generation of a long-lived NK cell population in lymphoid 
and non-lymphoid tissues. 
Because of the pleiotrophic effects complicating the direct infection of 
cytokine-deficient mice, it is unknown whether defective IL-12 signaling in NK 
cells alone will influence the course of viral infection (without loss of the IL-12R on 
other cell types). Thus, we examined the contribution of IL-12R signaling 
specifically in NK cells towards protection against MCMV infection. We 
transferred an equal number of purified NK cells from WT or Il12rb2-/- mice into 
neonatal DAP12-deficient mice. As a negative control, one group of neonates was 
given PBS without cells. All three groups were challenged with MCMV.  Within the 
first 2 weeks, all of the mice receiving PBS or purified Il12rb2-/- NK cells had died 
(Figure 2.3E). During the same period, greater than 50% of the mice given purified 
WT NK cells survived (Figure 2.3E). Together, the data suggest that IL-12 signaling 
in NK cells alone is crucial for protective immunity against viral challenge. 
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Interestingly, the mice receiving Il12rb2-/- NK cells died with delayed kinetics (days 
9-15 PI) compared to mice receiving PBS (days 5-12 PI), perhaps because the 
Il12rb2-/- NK cells could still mediate cytotoxicity against infected cells; however, 
their inability to undergo proliferation similar to WT NK cells might have prevented 
a more efficacious response. 
 
NK cell memory depends on STAT4 signals, but not IFN-γ secretion 
We investigated the importance of effector molecules downstream of the IL-12R in 
the generation of long-lived memory NK cells during MCMV infection. Because 
Il12rb2-/- NK cells do not efficiently phosphorylate STAT4 or secrete as much IFN-
γ as WT NK cells during MCMV infection (Figure 2.2E), we examined the 
contribution of both STAT4 and IFN-γ on the production of effector and memory 
Ly49H+ NK cells. To elucidate the importance of downstream effector molecule 
STAT4 on in vivo NK cell activation and response against MCMV, we generated 
mixed bone marrow chimeric mice. Reconstitution of all immune populations, 
including the NK compartment, was found to be equally distributed between WT 
and Stat4-/- (Figure 2.4A and data not shown).  Following MCMV infection, 
wildtype NK cells preferentially expanded over 7 days to constitute the main subset 
in the spleen and liver, exhibiting 5-fold greater numbers compared to Stat4-/- NK 
cells (Figure 2.4A-B), similar to that seen for mixed WT:Il12rb2-/- bone marrow 
chimeras (Figure 2.2A). In both organs, the prolific expansion of WT NK cells can 
be attributed to the proliferation of Ly49H-bearing cells (Figure 2.4C).  Whereas 
uninfected mice had comparable numbers of WT and Stat4-/- NK cells, by day 7 PI  
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Figure 2.4. Wildtype NK cells out-compete Stat4-/- NK cells during MCMV 
infection.  (A) Mixed bone marrow chimeric mice were infected with MCMV and 
percentages of WT (CD45.1+) and Stat4-/- (CD45.2+) NK cells in spleen and liver are 
shown for uninfected mice and various time points PI. (B) The graph shows absolute 
numbers of WT and Stat4-/- NK cells in spleen and liver on day 0 and 7 PI. Error bars 
show s.e.m. (n = 3–5). (C) Percentages of Ly49H+ cells within the WT and Stat4-/- NK 
cell population in spleen and liver are shown for uninfected mice and various time 
points PI. (D) The graph shows absolute numbers of WT and Stat4-/- Ly49H+ NK cells 
in spleen and liver on day 0 and 7 PI. Error bars show s.e.m. (n = 3–5). (E) Expression 
of CD69, CD27, CD11b, and CD90, and production of IFN-γ are shown for WT and 
Stat4-/- NK cells (compared to uninfected mice) at day 1.5 PI. (F) Expression of 
KLRG1, CD90, Ly49C/I, and CD27 are shown for WT and Stat4-/- Ly49H+ NK cells 
(compared to uninfected mice) at day 7 PI. All data are representative of three 
experiments with 3-5 mice per time point.  
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the WT Ly49H+ NK cells outnumbered their Stat4-/- counterparts in absolute 
numbers by approximately 10-fold in spleen and liver (Figure 2.4D).  Early after 
infection, Stat4-/- NK cells produced less IFN-γ than WT NK cells, even though 
CD69 was similarly upregulated in both subsets at day 1.5 PI (Figure 2.4E).  
Although WT and Stat4-/- NK cells similarly downregulated CD27 and upregulated 
CD11b at day 1.5 PI, phenotypic differences were evident at day 7 PI in spleen and 
liver, with WT NK cells strongly downregulating CD27 and upregulating KLRG1 
(Figure 2.4E). Together, these findings suggest that IL-12-induced signaling in 
virus-specific NK cells primarily uses the downstream STAT4 to initiate vital 
signals for a complete cell maturation program during MCMV infection. 
Interestingly, both WT and Stat4-/- NK cells at day 7 PI highly expressed CD90 
(Thy-1) (Figure 2.4F), a marker described to be present on memory NK cells (79, 
80), and were predominantly Ly49C/I- (Figure 2.4F), consistent with previous data 
demonstrating that Ly49C/I- or “unlicensed” NK cells in C57BL/6 mice dominate 
the NK cell response to MCMV (81).    
We investigated the extent to which signaling through STAT4 influenced the 
generation of memory NK cells during MCMV infection. We transferred an equal 
number of Ly49H+ NK cells purified from WT (CD45.1) and Stat4-/- (CD45.2) mice 
into a Ly49H-deficient host (CD45.2). Transferred WT Ly49H+ NK cells 
proliferated robustly following MCMV infection, in contrast to the minimal 
expansion of transferred Stat4-/- Ly49H+ NK cells in the same host (Figure 2.5A).  
The percentage of WT NK cells at day 7 PI was approximately 10-fold higher than 
that of the co-transferred Stat4-/- counterparts (Figure 2.5B), highlighting the  
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Figure 8 
Figure 2.5. Defective memory NK cell generation in the absence of STAT4.  (A) A 
total of 1x105 WT (CD45.1+) and Stat4-/- (CD45.2+) Ly49H+ NK cells were co-
transferred into Ly49H-deficient mice (CD45.2+) and infected with MCMV. Plots are 
gated on total NK cells and percentages of adoptively transferred Ly49H+ NK cells 
(wildtype in upper left quadrant and Stat4-/- in upper right quadrant) are shown for 
each time point PI. (B) Percentage of adoptively transferred WT and Stat4-/- Ly49H+ 
NK cells within the total NK cell population are shown. Error bars show s.e.m. (n = 
3). All data are representative of three experiments with 3-4 mice per time point. 
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importance of signaling through STAT4 in the expansion of virus-specific NK cells 
following MCMV infection and in the attainment of a long-lived memory NK cell 
population.  
 Lastly, we examined a possible autocrine role for IFN-γ produced by NK 
cells during infection. Because WT NK cells produced more IFN-γ than Il12rb2-/- or 
Stat4-/- NK cells early during MCMV infection, could this IFN-γ “feedback” on the 
NK cells themselves and drive stronger proliferation and generation of memory 
cells? We first generated mixed bone marrow chimeric mice consisting of a 1:1 ratio 
of WT:Ifngr-/- hematopoietic cells. Following MCMV infection of chimeric mice, 
WT and Ifngr-/- NK cells proliferated similarly over the first 7 days (Figure 2.6A), 
with nearly equal ratio of WT to Ifngr-/- NK cells. On day 7 PI, similar percentages 
of Ly49H-bearing cells existed in total WT and Ifngr-/- NK cell populations (Figure 
2.6A), suggesting that IFN-γ does not influence the ability of NK cells themselves 
to undergo expansion. On day 1.5 PI, expression of CD69 and secretion of IFN-γ 
were also independent of IFN-γ receptor expression on the NK cell (Figure 2.6B). 
Similarly, no phenotypic differences were observed between WT and Ifngr-/- NK 
cells at day 7 PI (data not shown). When we co-transferred equal numbers of 
enriched WT and Ifngr-/- NK cells into recipient mice followed by MCMV infection, 
we observed a similar expansion at day 7 PI and equal percentages of memory NK 
cells at day 50 PI (Figure 2.6C). Altogether, these data suggest that the robust 
generation of NK cell memory during MCMV infection requires STAT4-dependent, 
but IFN-γ independent signals.  
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Figure 2.6. Wildtype and Ifngr-/- NK cells expand equally and generate memory 
cells following MCMV infection.  (A) Mixed-bone-marrow chimeric mice consisting 
of a 1:1 mixture of WT (CD45.1+) and Ifngr-/- (CD45.2+) hematopoietic cells were 
infected with MCMV. Top row: percentages of total WT and Ifngr-/- NK cells (gated 
on CD3- NK1.1+) are shown for uninfected mice and at day 1.5 and 7 PI.  Bottom row: 
percentages of Ly49H+ cells within the WT and Ifngr-/- NK cell populations are 
shown. (B) Production of IFN-γ and expression of CD69 are shown for WT and Ifngr-
/- NK cells in chimeric mice (compared to uninfected chimeras) at day 1.5 PI. (C) WT 
(CD45.1+) and Ifngr-/- (CD45.2+) Ly49H+ NK cells were co-adoptively transferred into 
Ly49H-deficient mice and infected with MCMV. Plots are gated on transferred NK 
cells and percentages of WT and Ifngr-/- NK cells are shown for day 0, 7, and 50 PI. 
All data are representative of three experiments with 3-5 mice per time point. 
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The recent discovery that primed NK cells can become long-lived memory 
cells during infection begs the question of what the mechanisms are behind such a 
phenomena. Past studies using neutralizing antibodies and cytokine deficient mice 
did not specifically address whether there was an in vivo role for IL-12 on NK cells 
independent of global effects on other cell types (29, 72-76). Although these 
previous studies found a role for IL-12 in activating NK cells, our current study 
demonstrates the absolute requirement for both IL-12 and STAT4 in the clonal 
expansion of antigen-specific NK cells and the generation of memory NK cells 
during MCMV infection.  
The amount of inflammation in the host environment during CD8+ T cell 
priming has been suggested to dictate the production of effector and memory cells.  
In recent studies where the degree of inflammation was varied while antigen 
concentration was kept constant, memory CD8+ T cell potential was determined by 
a gradient of T-bet expression in which moderate inflammation correlated with 
robust memory cells, whereas high inflammation correlated with short-lived effector 
cells and reduced memory potential (24, 82).  Consistent with this study, another 
group showed that IL-12-deficient mice produced a diminished effector CD8+ T cell 
response during Listeria infection, but generated higher numbers of memory CD8+ 
T cells and greater protection against re-infection (78).  However, when mice 
receiving wildtype or IL-12R-deficient TCR transgenic CD8+ T cells were infected 
with viral pathogens, the conclusions were less clear.  One study observed normal 
clonal expansion but diminished memory responses in CD8+ T cells that could not 
sense IL-12 during vaccinia virus infection (83), whereas another study showed 
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normal effector and memory responses during infection with vaccinia virus, LCMV, 
and VSV (84).  These discrepancies may be due to different TCR transgenic mice 
and recombinant pathogens used in the studies, but highlight the need to resolve 
these inconsistencies.  
In contrast to the inconclusive role of IL-12 on T cells, the NK cell response 
in the absence of IL-12 signaling resulted in a severe detriment in both effector and 
memory NK cell numbers. During MCMV infection, the IL-12R-deficient Ly49H+ 
NK cells showed a remarkable 10- to 20-fold reduction in absolute number of 
effector cells in spleen and liver compared to WT NK cells, and a complete 
deficiency in memory cells. Even when effector NK cell numbers (isolated at day 7 
PI) were normalized, only WT NK cells could be detected at later time points 
following adoptive transfer (Figure 2.3D), suggesting that IL-12 signaling 
“programs” NK cells during priming to demonstrate longevity following activation 
and expansion. Unlike CD8+ T cells that expanded less in the absence of IL-12 but 
generated higher memory cell numbers (78), our results suggest an absolute 
requirement for IL-12 signals in the generation of memory NK cells. These findings 
are strengthened by the severe defect in clonal expansion and memory cell 
formation in STAT4-deficient NK cells.  Interestingly, we do observe some low 
level phosphorylation of STAT4 in the Il12rb2-/- NK cells compared to WT NK 
cells (Figure 2.2E), suggesting that other cytokines produced during MCMV 
infection may share the STAT4 signaling pathway.  IFN-α/β has been shown to 
activate STAT4 (in addition to STAT1) in T cells (40); however, findings in IFN-α 
receptor-deficient mice that STAT4 is normally phosphorylated during MCMV 
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infection suggest that IL-12 signaling is the predominant pathway for STAT4 
phosphorylation leading to IFN-γ production in NK cells (40) (Firth and Sun, 
unpublished observations). Developing a system for NK cells where we can vary the 
inflammation while keeping the antigen dose constant will allow us to determine 
whether, like CD8+ T cells, there exist optimal and sub-optimal degrees of 
inflammation that drive generation of effector and memory NK cells. In addition, 
the molecular mechanisms behind NK cell programming by IL-12 during MCMV 
infection remain to be elucidated. Future studies will determine how IL-12 signaling 
influences histone acetylation and chromatin remodeling at promoter sites of genes 
important for the generation of NK cell memory.  
Like NK cells, memory CD8+ T cells surprisingly possess the “innate-like” 
ability to produce IFN-γ and proliferate following exposure to pro-inflammatory 
cytokines alone, without TCR and costimulatory receptor ligation (85).  Given their 
relatedness during ontogeny (both are derived from a common lymphoid progenitor) 
and possible shared evolutionary ancestry, perhaps it is not surprising that parallel 
mechanisms exist in NK cells and T cells for their activation, proliferation, and 
generation of memory during infection. The importance of environmental cues, in 
addition to antigen receptor triggering, is becoming more evident, and a greater 
understanding of these mechanisms will allow for development of therapeutics and 
vaccines against infectious disease. 
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Materials and Methods 
Mice and infections. 
C57BL/6 and congenic CD45.1+ mice were purchased from the National Cancer 
Institute. IL-12 receptor β2 chain-deficient (75), STAT4-deficient (86), IFN-γ 
receptor-deficient, β2m-deficient, Ly49H-deficient (87), and DAP12-deficient (88) 
mice on a C57BL/6 background were bred at UCSF and MSKCC and maintained in 
accordance with the guidelines of the Institutional Animal Care and Use Committee. 
Mixed-bone-marrow chimeric mice were generated as described previously (13). 
Mice were infected by intraperitoneal injections of Smith strain MCMV (5  ×  104 
plaque-forming units (p.f.u.)). Newborn mice were infected with 2  ×  103 p.f.u. of 
MCMV. 
 
Flow cytometry. 
Fc receptors were blocked with 2.4G2 mAb before surface or intracellular staining 
with indicated antibodies or isotype-matched control immunoglobulin (BD, 
eBioscience, or BioLegend). For measuring apoptosis, freshly isolated splenocytes 
were first stained with antibodies against NK1.1, CD3, and Ly49H, and a Live/Dead 
fixable near-IR stain (Invitrogen), washed, and then stained with PE-conjugated 
Annexin V (BD), according to manufacture’s protocol. Samples were acquired on 
an LSRII (BD) and analyzed with FlowJo software (TreeStar). 
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NK cell enrichment, CFSE-labeling, and adoptive transfer. 
NK cells were enriched with an NK-cell Isolation Kit (Miltenyi Biotec) or a method 
where spleen cells were incubated with purified rat antibodies against mouse CD4, 
CD5, CD8, CD19, Gr-1, and Ter119 followed by anti-rat IgG antibodies conjugated 
to magnetic beads (Qiagen). Purified NK cells were injected intravenously into adult 
recipients or intraperitoneally into neonatal recipients one day before viral infection. 
In some experiments, NK cells or unfractionated splenocytes were labeled with 
varying concentrations of CFSE prior to intravenous injection. Labeling of cells 
with CFSE was performed in accordance with the manufacturer’s instructions 
(Invitrogen). 
 
Ex vivo stimulation of NK cells and cytotoxicity assay. 
Tissue culture plates treated with N-(1-(2,3-dioleoyloxyl)propyl)-N,N,N-
trimethylammonium methylsulphate (Sigma) were coated with anti-NK1.1 or anti-
Ly49H antibodies (10 µg/ml) and enriched NK cells or whole splenocytes were 
incubated for 5  h at 37  °C in the presence of Golgiplug (BD), followed by staining 
for intracellular cytokines. Uncoated or PBS-coated wells served as negative 
controls, and addition of PMA (50 ng/mL) and Ionomycin (1 µg/mL) during 
incubation served as a positive control.  
Enriched NK cells were used as effector cells ex vivo in a 6-h 51Cr release 
assay against Ba/F3 and m157-transfected Ba/F3 target cells. Percentage of Ly49H+ 
NK cells in each group was determined by flow cytometry and absolute numbers 
were normalized prior to incubation with targets. Large numbers of NK cells from 
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Ly49H-deficient mice were included as a negative control to demonstrate specificity 
of receptor-ligand interactions. 
 
Statistical methods. 
The Mann–Whitney nonparametric U-test was used to compare survival between 
groups of mice. A value of 25 days was assigned to survivors living more than 25 
days after MCMV infection. Student’s t-test was used to compare groups in ex vivo 
stimulation experiments. 
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Introduction 
Natural Killer (NK) cells play a significant role in the control of infected, stressed, 
or transformed cells that may be detrimental to the host. Recent studies in mice and 
humans have demonstrated that NK cells possess adaptive immune qualities (89). In 
mice infected with mouse cytomegalovirus (MCMV), Ly49H+ NK cells activated by 
the viral glycoprotein m157 undergo extensive proliferation, and contract resulting 
in the formation of a small pool of long-lived memory NK cells (13) that can be 
recalled, and exhibit heightened effector function (69, 89). 
Pro-inflammatory cytokines strongly influence the NK cell response against 
MCMV infection (90). Although previous work has described the effect of pro-
inflammatory cytokines on the general activation of NK cells during MCMV 
infection (90), their role in driving clonal-like expansion and memory in antigen-
specific NK cells is largely unknown. We previously implicated IL-12, its signaling 
molecule STAT4, and the downstream transcription factor Zbtb32 as crucial signals 
in the generation of robust effector and memory NK cell responses against MCMV 
infection (91, 92). IL-18 has been suggested to “prime” resting NK cells for 
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maximum IFN-γ production following ex vivo stimulation (48), and synergize with 
IL-12 during NK cell activation (93). Although IL-18 is produced early during 
MCMV infection (31), it is not known how IL-18 signals influence the virus-
specific Ly49H+ NK cell response. Here, we investigate the direct effects of IL-18 
signaling on primary and recall NK cell responses to MCMV infection.  
 
Results and Discussion 
Cell-Intrinsic IL-18 signaling required for the primary expansion of virus-specific 
NK cells 
Although IL-18 has previously been shown to activate NK cells during viral 
infection, these studies involve directly infecting IL-18- and IL-18 receptor-
deficient mice (31, 32).  Therefore, to address whether IL-18 influences NK cell 
responses in a cell-intrinsic manner, we adoptively transferred equal numbers of WT 
and Il18r1-/- NK cells into Ly49h-/- mice, which harbor normal numbers of NK cells 
but are incapable of recognizing the MCMV-derived m157 protein (13, 91). 
Following infection with MCMV, WT NK cells preferentially expanded during the 
first week of infection and were higher in frequency than Il18r1-/- NK cells at day 7 
post-infection (PI; Supplementary Figure 3.1A) and at later time points (Figure 
3.1A). Consistent with the adoptive transfer experiment, we observed a similar 
expansion defect by Il18r1-/- Ly49H+ NK cells in WT:Il18r1-/- mixed bone marrow 
chimeric mice infected with MCMV (Figure 3.1B and Supplementary Figure 3.1B).  
Together, these studies confirm a cell-intrinsic requirement for IL-18 signaling in 
the antiviral NK cell response.   
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Figure 10 
Figure 3.1. IL-18R-deficient NK cells mount a defective response to viral 
infection. A. WT and Il18r1-/- NK cells were co-transferred into Ly49h-/- mice and 
infected with MCMV. The relative ratio of populations is shown for each time point 
compared to day 0. B. Mixed WT:Il18r1-/- chimeric mice were infected with MCMV 
and the relative ratio of Ly49H+ NK cells are shown for day 7 PI compared to 
uninfected. C. Percentages of co-transferred WT and Il18-/- Ly49H+ NK cells are 
shown during MCMV infection. D. Percentages of co-transferred WT and Il18r1-/- 
Ly49H+ NK cells are shown following infection with MCMV, MCMV-Δm157, VSV-
m157, or VSV-Ova. E. WT and Il18r1-/- NK cells were co-transferred into Rag x 
Il2rg-/- mice and percentages of transferred Ly49H+ NK cells within the total cell 
population are shown. Data are mean ± s.e.m. representative of at least four 
independent experiments with at least n=3 biological replicates per condition. * p < 
0.05 and ns, not significant, paired Student t-test.  
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IL-18 has been suggested enhance IL-12-induced effector functions of NK 
cells such as IFN-γ production (48, 93). To determine if IL-18 might also “prime” 
NK cells for MCMV-driven expansion, we isolated resting NK cells from Il18-/- 
mice and co-transferred them with equal numbers of WT NK cells into Ly49h-/- 
hosts. Following MCMV infection, WT and Il18-/- Ly49H+ NK cells exhibited 
comparable expansion and memory cell formation (Figure 3.1C), indicating that 
previous exposure to IL-18 during development or homeostasis was not required for 
normal expansion in response to viral challenge as long as IL-18 is present during 
infection.  
To determine whether the effect of IL-18 signaling was limited to antigen-
specific NK cell responses, we utilized MCMV and VSV viruses engineered to lack 
or express m157, respectively. Following adoptive transfer of WT and Il18r1-/- NK 
cells into Ly49h-/- hosts, we observed that in contrast to MCMV, infection with 
MCMV lacking m157 (MCMV-Δm157) elicited an equivalent (albeit modest) 
expansion of both WT and Il18r1-/- NK cell populations (Figure 3.1D), indicating 
that IL-18 signaling is not required for the low-level proliferation of “bystander” 
NK cells responding to viral infection. Consistent with this observation, infection 
with VSV-m157, but not with VSV-Ova, elicited a preferential antigen-specific 
expansion of WT NK cells over Il18r1-/- NK cells (Figure 3.1D). We next 
investigated whether IL-18 was required for NK cells to undergo homeostatic 
proliferation. We found that WT and Il18r1-/- NK cells proliferated similarly when 
transferred into Rag2-/- x Il2rg-/- mice, generating comparable long-lived populations 
more than 4 weeks later (Figure 3.1E), demonstrating IL-18 signaling is not required 
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for NK cells to proliferate in response to common gamma chain cytokines. 
Altogether, these data suggest that IL-18 signaling directly regulates antigen-driven 
expansion of NK cells during viral infection, but not during bystander or 
homeostatic expansion. 
IL-18 signaling is necessary for optimal IFN-γ production and maturation of NK 
cells during infection 
Because IL-18 is required for optimal proliferation of NK cells during viral 
infection, we investigated additional NK cell effector functions that may be 
compromised in the absence of IL-18 signaling. At day 1.5 PI we observed that 
Il18r1-/- NK cells exhibited a defect in IFN-γ production, but not Granzyme B 
(Figure 2A), consistent with a previous report (31). Although both NK cell 
populations became similarly activated at days 1.5 and 7 PI (Supplementary Figure 
3.1C and 1D), WT NK cells were found to be more mature, as measured by CD27 
and CD11b staining, compared to Il18r1-/- cells (Figure 3.2B), suggesting IL-18 
may have a role in promoting the maturation of activated NK cells. 
Adoptive co-transfer and bone marrow chimeric studies revealed an 
expansion defect in the Il18r1-/- NK cell response to MCMV infection, which could 
be a consequence of decreased proliferation or increased apoptosis of Il18r1-/- NK 
cells relative to WT NK cells. We were not able to detect differences in BrdU 
incorporation, Ki67 staining, or CFSE dilution by WT and Il18r1-/- NK cells in 
MCMV-infected bone marrow chimeric mice (data not shown), consistent with a 
prior study (94). In addition, FLICA incorporation studies did not reveal any 
differences in pan-caspase activity between Il18r1-/- and WT NK cells on day 7 PI  
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Figure 11 
Figure 3.2. IL-18 is necessary for optimal NK cell maturation and IFN-γ 
production following MCMV infection. A. Mixed WT:Il18r1-/- chimeric mice were 
infected with MCMV and amount of IFN-γ and granzyme B in NK cells at day 1.5 PI 
are shown. B. WT and Il18r1-/- NK cells were co-transferred into Ly49h-/- mice and 
infected with MCMV. CD27 and CD11b staining is shown for WT and Il18r1-/- 
Ly49H+ NK cells at day 7 PI. C. Equal numbers of purified effector WT and Il18r1-/- 
NK cells (at day 7 PI) were co-transferred into a naïve Ly49h-/- host. Percentages of 
Ly49H+ NK cells are shown. Data are mean ± s.e.m. representative of at least 3 
independent experiments with at least n=3 biological replicates per condition. * p < 
0.05 and ns, not significant, paired Student t-test. 
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(Supplementary Figure 3.1E), suggesting that Il18r1-/- NK cells were not more 
susceptible to apoptosis. Lastly, when WT and Il18r1-/- effector NK cells were 
sorted from MCMV-infected hosts on day 7 PI, and equal numbers co-transferred 
into naïve recipients, the two populations contracted at similar rates (Figure 3.2C), 
indicating that Il18r1-/- NK cells are not undergoing increased cell death at later time 
points, and that IL-18 signaling does not regulate the contraction phase or 
maintenance of memory NK cells.  
 
Antiviral NK cell response depends on MyD88, but not the IL-1 receptor 
Because the IL-18 receptor requires the adapter molecule MyD88 for downstream 
signaling (95), we investigated the contribution of MyD88 to the NK cell response 
to MCMV infection. WT:Myd88-/- mixed bone marrow chimeric mice were 
generated and both NK cell populations reconstituted similarly (data not shown). 
Following MCMV infection, Myd88-/- Ly49H+ NK cells exhibited a cell-intrinsic 
expansion defect compared to WT NK cells (Figure 3.3A), similar to Il18r1-/- NK 
cells (Figure 1C). In addition, fewer Myd88-/- NK cells produced IFN-γ after 
MCMV infection despite comparable upregulation of CD69 (Figure 3.3B). Similar 
to Il18r1-/- NK cells, Myd88-/- NK cells failed to mature as efficiently as WT NK 
cells at day 7 PI (Figure 3.3C).  When equal numbers of WT and Myd88-/- NK cells 
were transferred into Ly49h-/- hosts followed by infection with MCMV, we observed 
preferential expansion and memory cell formation of the WT NK cells compared to 
Myd88-/- NK cells (Figure 3.3D). The IL-1 receptor, which is expressed by NK cells, 
is also known to use MyD88 for signaling (95); however, unlike Il18r1-/- or Myd88-/-  
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Figure 12 
Figure 3.3. MyD88-deficient NK cells exhibit defective proliferation during 
MCMV infection. A. WT: Myd88-/- chimeric mice were infected with MCMV and 
percentages of splenic NK cells are shown for uninfected and day 7 PI. B. CD69 and 
IFN-γ are shown for wildtype and Myd88-/- NK cells (compared to uninfected mice) at 
day 1.5 PI. C. CD27 and CD11b staining is shown for WT and Il18r1-/- Ly49H+ NK 
cells at day 7 PI. D. Percentages of co-transferred WT (CD45.1) and MyD88-/- 
(CD45.2) Ly49H+ NK cells are shown following MCMV infection. E. Percentages of 
co-transferred WT and Il1r-/- Ly49H+ NK cells are shown during MCMV infection. 
Data are mean ± s.e.m. representative of three independent experiments with at least 
n=3 biological replicates per condition. * p < 0.05 and ns, not significant, paired 
Student t-test. 
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NK cells, Il1r-/- NK cells expanded comparably to WT NK cells at day 7 PI (Figure 
3.3E) and showed similar effector function and phenotype as WT NK cells at days 
1.5 and 7 PI (Supplementary Figures 3.2A-C). These findings support a mechanism 
for IL-18 signaling on NK cells through a MyD88-dependent signaling axis.  
 
IL-12 signaling and STAT4 increase expression of MyD88 in activated NK cells 
During MCMV infection, we observed an increase in Myd88 expression in sorted 
NK cells by microarray and qRT-PCR (Figure 3.4A, data not shown). Given the 
important early role of IL-12 in activating NK cells, and a report that 
proinflammatory cytokines induce IL-18 signaling components in human NK cells 
(96), we investigated whether IL-12 directly influences the expression of the IL-18 
signaling machinery. Overnight stimulation of sorted NK cells with IL-12 and IL-18 
also showed an increase in the expression of Myd88 by qRT-PCR (Figure 3.4B). 
STAT4 is a transcription factor that mediates signals downstream from the IL-12 
receptor (97), and analysis of the Myd88 promoter revealed one putative STAT4 
binding site upstream of the transcriptional start site (Figure 3.4C). STAT4 ChIP 
followed by qRT-PCR identified a significant enrichment of STAT4 binding 
directly upstream of the Myd88 transcriptional start site (Figure 3.4D). This increase 
in STAT4 binding was dependent on IL-12 stimulation, suggesting Myd88 is a 
target gene of IL-12 signaling. Finally, we compared the expression of Myd88 in 
WT and Stat4-/- NK cells during MCMV infection. Activated Stat4-/- NK cells 
exhibited lower levels of Myd88 expression compared to WT NK cells. Altogether, 
these data indicate that IL-12 signaling acts through STAT4 to increase the  
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Figure 13 
Figure 3.4. IL-12 signaling induces expression of Myd88 in NK cells. A. qRT-PCR 
analysis of Myd88 mRNA abundance in NK cells sorted from the spleen of WT mice 
following infection with MCMV (n=4 biological replicates per condition). Fold 
expression is shown relative to naïve mice.  B. qRT-PCR analysis of Myd88 mRNA 
abundance in WT NK cells stimulated with IL-12 and IL-18 for 18 h (n=3 biological 
replicates per condition). Fold expression is shown relative to medium only. C. Vista 
browser image of mouse Myd88 promoter showing predicted STAT4 binding site. D. 
STAT4 binding at Myd88, Ifng, and control promoters as assessed through ChIP 
followed by qPCR in sorted WT NK cells stimulated with IL-12 and IL-18 for 18 h. 
STAT4 occupancy as percent of input is shown for target (Myd88) and control DNA 
(negative control: average of gene desert 50 kb upstream of Foxp3, Zfp42, and Utf1 
promoters; positive control: Ifng promoter). Data were confirmed in two independent 
experiments. E. qRT-PCR analysis of Myd88 mRNA abundance in Stat4-/- NK cells 
relative to WT NK cells from mice infected with MCMV (n=4 biological replicates 
per condition). Data are mean ± s.e.m. representative of three independent 
experiments. * p < 0.05, paired Student t-test. 
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expression of Myd88, identifying a novel role for IL-12 in potentiating IL-18 
signaling early during MCMV infection.  
 
IL-18 signaling is dispensable for recall responses by memory NK cells  
To assess whether IL-18 signaling regulates the functional capabilities of memory 
NK cells, we stimulated WT and Il18r1-/- memory NK cells with Ly49D, Ly49H, or 
IL-12 and IL-18 and measured their ability to degranulate and to make IFN-γ.  
Similar to resting NK cells, Il18r1-/- memory NK cells produced less IFN-γ than 
their WT counterparts only when stimulated with pro-inflammatory cytokines, but 
not with Ly49D, Ly49H or PMA and ionomycin (Figure 3.5A and data not shown). 
Il18r1-/- memory NK cells degranulated similarly to WT (Figure 3.5B). Thus, like 
resting NK cells (48), memory NK cells continue to depend on IL-18 for IL-12-
mediated IFN-γ production. 
Given the importance of IL-18 signaling on the optimal expansion of naïve 
NK cells during MCMV infection, we investigated its role during a recall response. 
Equal numbers of effector WT and Il18r1-/- NK cells were co-transferred and 
“parked” in a naïve host for three weeks, followed by infection with MCMV. 
Surprisingly, Il18r1-/- memory NK cells expanded similarly to their WT 
counterparts during secondary challenge by MCMV (Figure 3.5C), demonstrating a 
stage-specific requirement for IL-18 signals for proliferation.  Following the peak of 
expansion, both cell populations contributed to equal frequencies of secondary 
memory NK cells. Thus, IL-18 signaling is specifically required for the primary  
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Figure 14 
Figure 3.5. IL-18 signaling is dispensable for recall response of NK cells. Memory 
WT and Il18r1-/- NK cells were stimulated with Ly49D, IL-12 and IL18, or PMA and 
Ionomycin, and percent IFN-γ  (A) or CD107a (B) expression shown. C. Percentage of 
recalled WT and Il18r1-/- NK cells (at day 28 PI) are shown following secondary 
challenge with MCMV. Data are mean ± s.e.m. representative of five independent 
experiments with at least n=4 biological replicates per condition. * p < 0.05 or ns, not 
significant, paired Student t-test. 
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expansion of virus-specific NK cells, but is dispensable in the subsequent recall 
response.   
 
NK cells possess adaptive immune qualities in response to cytokine treatment (25) 
or exposure to pathogen and non-pathogen antigens (65). It is poorly understood 
what the cytokine signal requirements are in resting and memory NK cells. Here, we 
find a stage-specific requirement for IL-18, where IL-18 promotes the antigen-
specific primary expansion of resting NK cells, but not the recall response of 
memory NK cells. Furthermore, we have identified a previously unknown role for 
IL-12 in promoting the expression of Myd88 to enhance the IL-18 signaling 
cascade, and possibly sensitize NK cells to lower levels of IL-18 cytokine. 
Our current findings suggest that as naïve NK cells differentiate into 
antigen-experienced memory cells, they become “specialized” and may rely more 
on antigen-specific signals and less on pro-inflammatory cytokine signals for clonal-
like expansion. This mechanism would allow previously antigen experienced NK 
cells to respond more robustly during subsequent pathogen encounter. Because 
memory and recall NK cell responses have also been documented in humans 
following viral infection (89), determining whether a homologous role for IL-18 in 
the recall response of human NK cells may impact the use of this cytokine in 
clinical settings.  
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Materials and methods   
Mice and infections 
All mice used in this study were bred and maintained at MSKCC in accordance with 
IACUC guidelines. Mixed bone marrow chimeric mice were generated, and 
adoptive transfer studies and viral infections were performed as previously 
described (13).  
 
Flow cytometry and cell sorting 
Fc receptors were blocked with 2.4G2 mAb before staining with the indicated 
surface or intracellular antibodies (BD, BioLegend, or eBioscience). Flow 
cytometry was performed on an LSR II (BD). Cell sorting was performed on an 
Aria II cytometer (BD). All data were analyzed with FlowJo software (TreeStar). 
NK cell enrichment and adoptive transfers were performed as previously described 
(91).   
 
qRT-PCR and ChIP 
qRT-PCR and chromatin immunoprecipitation (ChIP) were performed as previously 
described (92). The following qRT- PCR primers were used: Myd88, For: 5’-
CACCTGTGTCTGGTCCATT-3’, Rev: 5’-AGGCTGAGTGCAAACTTG-3’; Actb, 
For: 5’-TGCGTGACATCAAAGAGAAG-3’, Rev: 5’-
CGGATGTCAACGTCACACTT-3’. The following qPCR primers were used for 
ChIP studies: Myd88 promoter, For: 5’-AAGTAGGAAACTCCACAGGCGAGC-3’, 
  54 
Rev: 5’-TTCAAGAACAGCGATAGGCGGC-3’; Gene desert 50 kB upstream of 
Foxp3, For: 5’-TAGCCAGAAGCTGGAAAGAAGCCA-3’, Rev: 5’-
TGATACCCTCCAGGTCCAACCATT-3’; Zpf42 promoter, For: 5’-
AGAGGGCGGTGTGTACTGTGGTG-3’, Rev: 5’-
CTTCTTCTTGCACCCGGCTTGAG-3’; Utf1 promoter, For: 5’-
AGTCGTTGAATACCGCGTTGCTG-3’, Rev: 5’-
CTGTTGAGATGTCGCCCAAGTGC-3’; Ifng promoter, For: 5’-
GCTCTGTGGATGAGAAAT-3’, Rev: 5’-GCTCTGTGGATGAGAAAT-3’. 
 
Ex vivo stimulation of NK cells 
Purified NK cells were stimulated for 4 h (memory cells) or 18 h (for ChIP), as 
previously described (92). Negative and positive controls include NK cells 
incubated with media only, or with PMA (50 ng/mL) and Ionomycin (1 µg/mL), 
respectively.  
 
Statistical methods 
All graphs depict mean ± s.e.m. Two-tailed paired Student’s t-test was used to 
derive statistical differences. A p value < 0.05 was considered significant. Plots and 
statistical analyses were produced in GraphPad Prism.  
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CHAPTER 4 
TYPE I IFN PROMOTES NK CELL EXPANSION DURING VIRAL INFECTION 
BY PROTECTING NK CELLS AGAINST FRATRICIDE 
Introduction 
Type I IFNs provide a potent line of anti-viral defense through direct and indirect 
effects on cells of the immune system leading to their activation and effector 
function (55, 98), and resulting in the attenuation of viral replication (99). IFN-α 
and IFN-β are among the most-studied members of the type I IFN family. All 
members of the type I IFN family signal through a ubiquitously expressed 
heterodimeric receptor that is composed of the IFNAR1 and IFNAR2 chains. Type I 
IFNs act directly on NK cells to promote their activation, cell-cycle entry, and 
cytotoxic function during viral infection (40, 54-56). However, the experimental 
systems employed in these previous studies – direct infection of cytokine receptor-
deficient mice or wildtype mice with cytokine neutralization – are complicated by 
potential differences in degree of inflammation, indirect cytokine effects, and viral 
load. Thus, efforts to delineate the direct influence of type I IFN on anti-viral NK 
cell responses, while eliminating pleiotropic effects, are lacking.  
Although substantial amounts of type I IFN are produced during viral 
infection, this cytokine is constitutively present at basal levels and affects the 
development and homeostasis of various hematopoietic lineages (100-102). An 
indirect effect of type I IFN on NK cell development and maturation has been 
described recently (103, 104). Because the prolific expansion and generation of 
memory NK cells during MCMV infection are dependent predominantly on the pro-
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inflammatory cytokines IL-12 and IL-18 (91, 105, 106), it was of interest whether 
type I IFNs play a role in these processes. Here, we use mice deficient in the 
IFNAR1 chain (Ifnar-/-) in an adoptive co-transfer system and in bone marrow 
chimeric mice to investigate the direct influence of type I IFN signaling on NK cells 
responding against MCMV infection.  
 
Results and Discussion 
Type I IFN and STAT1 are required for optimal NK cell responses following 
MCMV infection 
Given the pleiotropic effects of type I IFNs (107), we assessed the ability of Ifnar-/- 
and wildtype (WT) Ly49H+ NK cells to expand in response to MCMV infection 
using an adoptive co-transfer system (91), where both transferred NK cell 
populations respond against virus and experience similar inflammatory cues within 
the same host environment. WT and Ifnar-/- NK cells were co-transferred into 
Ly49H-deficient mice, whose NK cells are unable to recognize the virus-encoded 
glycoprotein m157 during MCMV infection and undergo clonal expansion (13). In 
contrast to the WT NK cells that robustly expanded following MCMV infection, 
Ifnar-/- NK cells failed to expand robustly (Figure 4.1A). Although they exhibited an 
expansion defect, Ifnar-/- NK cells were able to mature nearly as well as WT NK 
cells in response to MCMV infection, as evidenced by the downregulation of CD27 
and upregulation of CD11b and KLRG1 (Figures 4.1B and C). We also investigated  
  57 
 
0 5 10 15 20
0
50
100
Days post-infection
P
er
ce
nt
 s
ur
vi
va
l Wildtype 
Ifnar-/- 
PBS 
0 10 20 30
0
5
10
15
Days post-infection
%
 L
y4
9H
+  N
K
 c
el
ls Wildtype
Ifnar -/-
KLRG1
%
 o
f M
ax
0 102 103 104 105
0
102
103
104
105 0.9 8.4
89.7
0 102 103 104 105
CD11b
0
102
103
104
105
C
D
27
0 1.4
97.2
Wildtype Ifnar -/-
A B
C
D
Figure 1
Wildtype
Ifnar-/-
0 102 103 104 105
0
20
40
60
80
100
 
Figure 15 
Figure 4.1. Type I IFN is essential for a robust and protective anti-viral NK cell 
response following MCMV infection.  (A) WT and Ifnar-/- NK cells were co-
transferred into a Ly49H-deficient host and infected with MCMV. Percentages of 
Ly49H+ NK cells are shown. (B-C) CD27 versus CD11b, and KLRG1 staining are 
shown for WT and Ifnar-/- Ly49H+ NK cells at day 7 PI. (D) Neonatal mice received 
106 WT (n=13) or Ifnar-/- (n=7) NK cells followed by MCMV infection. Control mice 
received PBS (n=10). The percentage of surviving mice is shown for each group. Data 
were pooled from three experiments, and represent mean ± s.e.m. of at least three 
independent experiments with at least n=3 biological replicates per condition.  
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the contribution of type I IFN signaling in NK cells for protection against lethal 
MCMV challenge. Equal numbers of naïve WT or Ifnar-/- NK cells were transferred 
into separate neonatal mice and then challenged with MCMV. In contrast to mice 
receiving WT NK cells, which protected approximately 50% of recipients, all mice 
receiving Ifnar-/- NK cells succumbed to infection by day 15 post-infection (PI) 
(Figure 4.1D), highlighting the importance of type I IFN signaling specifically in 
NK cells for protective immunity against viral challenge.  
 Type I IFNs signal through STAT1-STAT2 heterodimers and STAT1-
STAT1 homodimers (108). Therefore, we determined the role of STAT1 in the NK 
cell response to MCMV infection using STAT1-deficient mice. Equal numbers of 
WT and Stat1-/- Ly49H+ NK cells were co-transferred into Ly49H-deficient hosts 
and then infected with MCMV. Similar to Ifnar-/- NK cells, Stat1-/- NK cells 
exhibited a striking defect in expansion during the immune response to MCMV 
infection (Figure 4.2A), even though Stat1-/- NK cells were able to mature nearly as 
well as WT NK cells following infection (Figures 4.2B and C). These data support 
the importance of STAT1-mediated type I IFN signaling in NK cells for an optimal 
antiviral NK cell response.  
 
Type I IFN is required for activation and effector function in NK cells following 
MCMV infection 
Type I IFN has both direct and indirect effects on NK cell development and 
maturation (103, 104).  In accordance with these prior reports, resting splenic NK 
cells from Ifnar-/- mice exhibited an increase in immature NK cells as indicated by  
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Figure 16 
Figure 4.2. Stat1-/- NK cells have a defective expansion during MCMV infection.  
(A) WT and Stat1-/- NK cells were co-transferred into a Ly49H-deficient host and 
infected with MCMV. Percentages of Ly49H NK cells are shown. (B-C) CD27 versus 
CD11b, and KLRG1 staining are shown for WT and Stat1-/- Ly49H+ NK cells at day 7 
PI.  Data are mean ± s.e.m. and representative of at least 3 independent experiments 
with at least n=3 biological replicates per condition.  
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CD27, CD11b, and KLRG1 expression when compared to WT (data not shown). 
Thus, we generated mixed WT:Ifnar-/- bone marrow chimeras, where development 
of Ifnar-/- NK cells appeared grossly normal (data not shown), and investigated the 
role of type I IFNs on the NK cell response against MCMV infection. At day 1.5 
following MCMV infection, Ifnar-/- NK cells in mixed chimeric mice exhibited 
defective upregulation of CD69 (Figure 4.3A), a marker of activation downstream 
of type I IFN signaling (109). Ifnar-/- NK cells also failed to upregulate granzyme B 
compared to their WT counterparts at day 1.5 PI (Figure 4.3B), consistent with a 
previous study that found a requirement for type I IFN signaling in NK cells for the 
induction of cytotoxicity following MCMV infection (40). Interestingly, Ifnar-/- NK 
cells produced more IFN-γ than WT NK cells at day 1.5 PI (Figure 4.3B). STAT1 
phosphorylation was completely ablated in NK cells that cannot sense type I IFNs 
(Figure 4.3C).  These findings demonstrate the ability of type I IFNs to directly 
impact the expression of key effector molecules in NK cells, likely via robust 
STAT1 phosphorylation.   
 Given the rescue of the maturation defect of Ifnar-/- NK cells in mixed bone 
marrow chimeric mice (104), we assessed the ability of Ly49H+ Ifnar-/- and Stat1-/- 
NK cells from mixed chimeras to undergo clonal expansion in response to MCMV 
infection. Following adoptive transfer and infection, Ifnar-/- NK cells were unable to 
expand as robustly as their WT counterparts (Figure 4.3D). Similarly, mixed 
chimera-derived Stat1-/- NK cells also exhibited a marked defect in expansion 
following MCMV infection compared to WT NK cells (Figure 4.3E). Long-lived 
NK were also diminished in NK cell populations that lack IFNAR or STAT1  
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Figure 17 
Figure 4.3. Type I IFN promotes NK cell activation and expression of effector 
molecules following MCMV infection.  (A-B) WT: Ifnar-/- chimeric mice were 
infected with MCMV. CD69, IFN-γ, and granzyme B are shown for splenic wildtype 
and Ifnar-/- NK cells (compared to uninfected mice) at day 1.5 PI. (C) STAT1 
phosphorylation of NK cells at day 1.5 PI is shown, and bar graphs plot MFI. (D-E) 
Ly49H+ NK cells from WT: Ifnar-/- chimeric mice (D) or WT:Stat1-/- chimeric mice 
(E) were transferred into Ly49H-deficient hosts and infected with MCMV. 
Percentages of Ly49H+ NK cells are shown. Data are mean ± s.e.m. and representative 
of three independent experiments with at least n=3 biological replicates per condition. 
* p <0.05 and ns, not significant, paired Student t-test. 
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(Figure 4.3D-E), highlighting the critical role of type I IFN signaling in NK cells for 
a robust viral-specific response.  
 
Type I IFN is dispensable for NK cell proliferation, but shields NK cells against 
apoptosis following MCMV infection 
We explored two possibilities for the expansion defect of Ifnar-/- NK cells in 
response to MCMV infection: proliferation and apoptosis. To investigate whether a 
proliferative defect exists in NK cells that are unable to sense type I IFNs, Cell 
Trace Violet (CTV)-labeled Ly49H+ NK cells from WT:Ifnar-/- chimeras were 
transferred into Ly49H-deficient hosts and infected with MCMV. Ifnar-/- NK cells 
exhibited a modest increase in proliferation when compared to WT NK cells at day 
4 PI (Figure 4.4A), suggesting type I IFN signals actually restrain NK cell 
proliferation following activation. We next compared the amount of apoptosis in 
Ifnar-/- and WT NK cells that are activated during MCMV infection. Following 
adoptive transfer and MCMV infection, Ifnar-/- NK cells incorporated significantly 
more FLICA, a measurement of activated caspases, than WT NK cells at day 4 PI 
(Figure 4.4B, 2.1% ± 0.5 vs. 12.0 ± 1.8, respectively; p=0.006).  Together, these 
findings suggest that type I IFNs shield activated NK cells from cell death during 
viral infection.  
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Figure 18 
Figure 4.4. Ifnar-/- NK cells proliferate normally but undergo greater apoptosis 
during MCMV infection.   (A) Ly49H+ NK cells from WT: Ifnar-/- chimeric mice 
were labeled with 5 µM CTV, transferred into a Ly49H-deficient host, and infected 
with MCMV. Proliferating cells were analyzed at day 4 PI.  Bar graph shows 
percentages of divided and non-divided NK cells at day 4 PI for each group. (B) 
FLICA incorporation is shown in plots, and bar graph shows percentages of FLICA+ 
NK cells in each group. Data are mean ± s.e.m., and representative of three 
independent experiments with at least n=3 biological replicates per condition. * p < 
0.05 and ns, not significant, paired Student t-test. 
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Type I IFN protects NK cells from fratricide via a perforin- and NKG2D-
dependent mechanism 
To evaluate whether host NK cells were killing Ifnar-/- NK cells, we transferred 
equal numbers of WT and Ifnar-/- NK cells into WT or perforin-deficient (Prf1-/-) 
hosts and infected with lymphocytic choriomeningitis virus (LCMV). LCMV 
infection elicits a strong type I IFN response (90), but does not drive the antigen-
specific proliferation of Ly49H+ NK cells observed during MCMV infection, thus 
ruling out the influence of the m157-Ly49H interaction in determining relative NK 
cell numbers. Following adoptive transfer and LCMV infection in WT hosts, WT 
NK cells persisted whereas the percentage of Ifnar-/- NK cells diminished over time 
(Figure 4.5A). However, Ifnar-/- NK cells transferred into Prf1-/- hosts were able to 
persist, and interestingly larger percentages were observed compared to the co-
transferred WT NK cell population (Figure 4.5A), uncovering a novel role for type I 
IFNs in protecting NK cells against perforin-mediated elimination. To confirm that 
the elimination of Ifnar-/- NK cells in WT mice was due to host NK cells, and not 
CD8+ T cells or another cell source, we transferred equal numbers of WT and Ifnar-
/- NK cells into WT or NKp46Cre x R26DTA hosts and infected with LCMV. 
NKp46Cre x R26DTA mice express the Cre recombinase under the control of the 
NKp46 promoter and possess a loxP-flanked stop cassette followed by a diphtheria 
toxin A, thus creating a host where all NK cells are ablated. LCMV infection 
revealed a predominance of transferred WT NK cells compared to Ifnar-/- NK cells 
in WT hosts, which was not observed in NKp46Cre x R26DTA hosts (Figure 4.5B). 
Similar to the perforin-deficient hosts, NKp46Cre x R26DTA hosts revealed a higher  
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Figure 19 
Figure 4.5. Type I IFN protects against perforin- and NKG2D-dependent NK cell 
fratricide during viral infection.  (A) NK cells from WT:Ifnar-/- chimeric mice were 
labeled with CTV and transferred into WT or Prf1-/- hosts followed by infection with 
LCMV. Bar graph shows percentages of transferred cells for each group at different 
points during infection in blood. (B) NK cells from WT:Ifnar-/- chimeric mice were 
labeled with CTV and transferred into WT or NKp46Cre x R26DTA hosts, followed by 
LCMV infection. Bar graph shows percentages of transferred cells for each group in 
spleen at day 3 PI. (C) NK cells from WT:Ifnar-/- chimeric mice were labeled with 
CTV and transferred into WT hosts receiving anti-NKG2D antibody or PBS, followed 
by LCMV infection. Bar graph shows percentages of transfer cells for each group in 
spleen at day 3 PI. (D) WT:Ifnar-/- chimeric mice were directly infected with LCMV. 
Expression of NKG2D ligands is shown at day 2 PI. Data are mean ± s.e.m. and 
representative of 3 independent experiments with at least n=3 biological replicates per 
condition. * p <0.05 or ns, not significant, paired Student t-test. 
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percentage of Ifnar-/- NK cells compared to WT NK cells following infection. Thus, 
these findings support a perforin-dependent NK cell-mediated elimination of NK 
cells that are unable to sense type I IFNs during viral infection. 
 In order to further uncover the mechanism behind NK cell-mediated 
fratricide, we investigated NKG2D triggering in NK cells as a potential activating 
signal involved in the killing of Ifnar-/- NK cells during viral infection. Equal 
numbers of WT and Ifnar-/- NK cells were co-transferred into WT hosts that 
received a non-depleting, neutralizing anti-NKG2D-blocking antibody (or PBS as a 
negative control) and then infected with LCMV. As expected, WT NK cells 
preferentially survived compared to Ifnar-/- NK cells in the PBS-treated control mice 
(Figure 4.5C). However, in mice receiving anti-NKG2D, similar persistence 
between WT and Ifnar-/- NK cells was observed (Figure 4.5C), suggesting that the 
NKG2D pathway may represent at least one mechanism that activates fratricide. 
Furthermore, we confirmed expression of NKG2D ligands on the NK cells soon 
after infection. Following LCMV infection of WT:Ifnar-/- bone marrow chimeras, 
Ifnar-/- NK cells expressed significantly higher amounts NKG2D ligand (Figure 
4.5D). This finding suggests type I IFN may have a direct role in suppressing 
NKG2D ligand induction during viral infection. Taken together, these data indicate 
that type I IFN acts to combat NK cell-mediated fratricide that is dependent on 
NKG2D triggering and perforin release.  
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Type I IFN is dispensable for NK cell survival and memory formation during 
MCMV infection in mice lacking WT NK cells 
If host NK cells are indeed mediating fratricide of transferred Ifnar-/- NK cells 
during viral infection, we hypothesized that Ifnar-/- NK cells should expand 
normally and generate long-lived memory following MCMV infection in a system 
devoid of NK cells. Equal numbers of Ly49H+ WT (CD45.1) and Ifnar-/- (CD45.2) 
NK cells from mixed chimeric mice were transferred into Rag2-/- x Il2rg-/- hosts 
(which lack T, B, and NK cells) and infected with MCMV. Following MCMV 
infection, Ifnar-/- NK cells expanded robustly, and even exhibited a moderate 
increase in percentage compared to WT NK cells at day 7 PI (Figure 4.6A). 
Activation and maturation of virus-specific Ifnar-/- NK cells was nearly identical to 
WT NK cells, as evidenced by CD27, CD11b, and KLRG1 expression (data not 
shown). Furthermore, Ifnar-/- NK cells could be recovered in comparable numbers 
and phenotype to WT NK cells at greater than 4 weeks PI (Figure 4.6B-D), 
revealing the ability of Ifnar-/- NK cells to generate a long-lived memory pool 
during infection in hosts lacking wildtype NK cells.  
 
Traditionally classified as a member of the innate immune system, NK cells are 
known to provide a crucial line of early defense against viral infections in both 
humans and mice (110-112). In more recent years, NK cells have been described to 
possess many features of adaptive immunity (67, 113). However, the molecular 
mechanisms behind these adaptive responses are not well understood. Although 
type I IFN has long been known to mediate antiviral effects, partly through its  
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Figure 20 
Figure 4.6.  Type I IFN is dispensable for NK cell survival and memory 
formation in Rag2 x Il2rg-/- hosts.  NK cells from WT:Ifnar-/- chimeric mice were co-
transferred into Rag2-/- x Il2rg-/- hosts and infected with MCMV. Percentages and 
phenotype of WT (CD45.1) and Ifnar-/- (CD45.2) NK cells is shown at days 7 PI (A) 
and 30 PI (B-E). 
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activity on NK cells (40, 54), previous studies have failed to distinguish between the 
direct and indirect role of type I IFNs on NK cells during infection.  Our current 
study demonstrates that type I IFN acts directly on NK cells to promote their 
survival by protecting them from elimination via NK cell-mediated fratricide.  
 We demonstrate that NK cells unable to sense type I IFNs can proliferate 
normally, but undergo more apoptosis than WT NK cells following MCMV 
infection. Although our findings suggests that a perforin- and NKG2D-dependent 
fratricide plays a major role in the increased cell death observed in Ifnar-/- NK cells 
during viral infection, additional survival mechanisms may be lacking in these cells. 
Type I IFN has been previously described to promote the survival of activated CD8+ 
T cells in a manner that is independent of Bcl-2 (114). Similarly, we found no 
difference in the expression of Bcl-2 between WT and Ifnar-/- NK cells following 
MCMV infection (data not shown). Thus, a Bcl-2-independent mechanism is 
promoting survival of antigen-specific NK cells that can sense type I IFNs, 
shielding these cells from apoptosis. Future studies investigating gene targets of 
STAT1 may reveal additional pro-survival mechanisms in NK cells exposed to type 
I IFNs during viral infection. 
We previously demonstrated that the pro-inflammatory cytokine IL-12 and 
downstream signaling components STAT4 and Zbtb32 are critical for the clonal-like 
proliferation of Ly49H+ NK cells during MCMV infection (91, 92). Interestingly, 
the expansion defect in Ifnar-/- NK cells is nearly as pronounced as that of the Il12rb-
/- NK cells, demonstrating a non-redundant role for these cytokines in promoting 
NK cell expansion. Based on our current findings, we propose a complementary role 
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for IL-12 and type I IFN in simultaneously driving cellular proliferation and 
protecting against cell death via fratricide, respectively, during virus-specific NK 
cell expansion. Given the use of type I IFN in the clinic and its potential impact in 
vaccination strategies, it is important to elucidate the direct and indirect roles this 
cytokine has on specific cellular compartments during the immune response. Our 
work brings us one step closer by uncovering a novel protective role of type I IFN 
signaling in NK cells during viral infection.  
 
Materials and Methods 
Mice and infections 
All of the mice used in this study were bred and maintained at MSKCC in 
accordance with IACUC guidelines. Adoptive transfer studies, the generation of 
mixed bone marrow chimeric mice, and MCMV infections were performed as 
previously described (13). LCMV infection was performed as described (115). In 
vivo blockade of NKG2D signaling was accomplished by intraperitoneal injection 
of purified antibody for NKG2D (clone CX5, 200 µg/mouse) receptor at d0 PI 
LCMV infection. In proliferation assays, NK cells were labeled with 5 µM Cell 
Trace Violet (Invitrogen) before transfer. 
 
Flow cytometry and cell sorting 
Blocking of Fc receptors was performed with 2.4G2 mAb before staining with the 
indicated surface or intracellular antibodies (BD, BioLegend, or eBioscience).  All 
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flow cytometry was performed on an LSR II (BD). The data were analyzed using 
FlowJo software (TreeStar). The enrichment and adoptive transfer of NK cells were 
performed as previously described (91).   
Statistical methods 
Mean ± s.e.m is depicted in all graphs. A two-tailed unpaired Student’s t-test was 
used to determine statistical differences. Statistical significance was assigned to p 
values <0.05.All statistical analyses and plots were produced in GraphPad Prism. 
  72 
CHAPTER 5 
DISTINCT STAGE-SPECIFIC FUNCTION OF T-BOX TRANSCRIPTION 
FACTORS IN THE ANTIVIRAL NK CELL RESPONSE 
Introduction 
Although NK cells have been classically regarded as cells of innate immunity, they 
are now appreciated to possess developmental and functional traits in common with 
T and B cells of adaptive immunity (89). In particular, a subset of NK cells 
expressing the Ly49H receptor, which can bind the mouse cytomegalovirus 
(MCMV)-encoded glycoprotein m157, will undergo a clonal-like proliferation and 
generate long-lived memory cells (13) similar to antigen-specific CD8+ T cells 
encountering pathogen-derived peptides presented on MHC class I. Recently, it has 
been demonstrated that pro-inflammatory interleukin (IL)-12 and STAT4 signals 
induce the pro-proliferative factor Zbtb32 (92), and all three are required for 
MCMV-specific expansion and “memory” of Ly49H+ NK cells (91, 92). Further 
mechanisms governing the transcriptional regulation of NK cells during viral 
infection remains to be elucidated. 
T-box family transcription factors Eomes and T-bet have wide-ranging 
effects that direct lymphocyte immunity. The role of T-bet and Eomes in the 
response of CD8+ T cells against pathogens has been well characterized (58, 59). 
More recently, several groups have described the importance of Eomes and T-bet in 
NK cell development and function (58, 60-62). Similar to effector and memory 
CD8+ T cells, mature NK cells exhibit constitutive T-bet and Eomes expression (60, 
63).  T-bet and Eomes have been described to control specific checkpoints of NK 
  73 
cell development and maturation, with expression of DX5, loss of TRAIL, and gain 
of Ly49 receptor diversity (all characteristics of NK cell maturation) being 
dependent on Eomes (61). In the liver, T-bet was shown to control the development 
of a distinct Eomes- NK cell lineage (62). The role of these transcription factors on 
the antiviral response of mature NK cells has not been studied.  
In this study, we use an inducible gene deletion system to probe the effects 
of single T-box family transcription factor ablation in Ly49H+ NK cells at various 
time points during MCMV infection. We demonstrate that T-bet and Eomes possess 
non-redundant functions in the antiviral NK cell response and generation of NK cell 
“memory”.  Although both transcription factors were critical for the proliferative 
burst of virus-specific NK cells, only continuous T-bet expression was required 
during the memory maintenance phase for the persistence of virus-experienced NK 
cells.  
 
Results 
T-box transcription factors dispensable for homeostatic turnover and proliferation 
of NK cells 
We generated mice containing a floxed Eomes or T-bet gene along with a Cre 
recombinase-human estrogen receptor ligand-binding domain (ERT2) fusion protein 
expressed downstream of the ubiquitin promoter (Ub) (Eomesf/f x UbCre-ERT2 or 
Tbx21f/f x UbCre-ERT2 mice, respectively). Treatment of Eomesf/f x UbCre-ERT2 or 
Tbx21f/f x UbCre-ERT2 mice with tamoxifen causes the specific excision of the floxed 
T-box transcription factor gene (Figure 5.1A and data not shown). This inducible  
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Figure 5.1. Eomes and T-bet are dispensable for NK cell homeostasis in both 
normal and lymphopenic mice. (A) Schematic of tamoxifen treatment. Mice were 
given a regimen of tamoxifen on days 0, 1, and 3. Control mice received oil. Panel 
shows expression of Eomes in NK cells three weeks after Eomesf/f UbCre+ mice were 
given tamoxifen. Gates show Eomes-/- population in mice receiving tamoxifen. (B-G) 
WT (CD45.1) and Eomesf/f UbCre+ (CD45.2, B-D) or T-betf/f UbCre+ (CD45.2, E-G) 
NK cells were co-transferred into WT (CD45.1x2) mice and treated with tamoxifen or 
oil at day 0 PT. The relative fold change of the floxed and WT NK cell ratio relative to 
their starting ratio is shown in panels B and E. Assessment of phenotypic markers at 
least one week post transfer for the spleen (C and F) and liver (D and G) are shown. 
Data are representative of two experiments with at least 3 mice in each condition. (H) 
WT (CD45.1) and Eomesf/f UbCre+ (CD45.2) or T-betf/f UbCre+ (CD45.2) NK cells 
were co-transferred into Rag-/- x Il2rg-/- mice and treated with tamoxifen or oil. (I and 
J) The ratio of floxed and WT NK cells at day 9 PT relative to their starting ratio is 
shown. Assessment of phenotypic expression in the spleen is shown. Data are 
representative of one experiment, with 2-3 mice per condition. * p < 0.05 and ns, not 
significant, paired Student t-test. 
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gene deletion system allows us to individually delete Eomes or T-bet at steady state, 
and at different time points throughout MCMV infection, allowing us to distinguish 
the influence of individual T-box transcription factors on NK cell homeostasis and 
antiviral response. (Cells where Eomes or T-bet are ablated following tamoxifen 
treatment will be shown in figures as Eomes-/- or T-bet-/-, respectively.) 
We first investigated the role of Eomes expression in resting mature NK 
cells. We isolated resting NK cells from the spleen of Eomesf/f x UbCre-ERT2 mice 
(CD45.2) and co-transferred them with equal numbers of WT NK cells (CD45.1) 
into CD45.1 x CD45.2 WT hosts. Host mice were immediately started on a 
tamoxifen regimen to induce Eomes deletion. Greater than one week following 
tamoxifen treatment, we found equal numbers of Eomes floxed and WT NK cells 
(Figure 5.1B), suggesting Eomes is not necessary for the maintenance of NK cell 
numbers under steady state conditions. However, NK cells that deleted Eomes 
exhibited an increase in the percentage TRAIL+ cells and a decrease in the 
percentage Ly49H+ cells in both the spleen and liver (Figure 5.1C-D). Using CD27 
and CD11b as markers of NK cell maturation (116), no significant changes were 
observed between Eomes floxed and WT NK cells (Figure 5.1C). When Tbx21f/f x 
UbCre-ERT2 NK cells were transferred with WT NK cells and hosts treated with 
tamoxifen, equal numbers of transferred populations were recovered one week later 
(Figure 5.1E), suggesting T-bet is also not essential for the maintenance of mature 
NK cells at steady state. In contrast to Eomes deletion, NK cells that deleted T-bet 
exhibited a decrease in the percentage of TRAIL+ NK cells, and increase in the 
percentages of Ly49H+ NK cells in the spleen and liver (Figure 5.1F-G). A 
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significant increase in the percentage of CD27+ CD11b+ cells was also observed 
(Figure 5.1F).  In all experiments, a control set of mice receiving oil only (without 
tamoxifen) showed no phenotypic differences between floxed and WT cells (data 
not shown). Similar observations were made when resting splenic NK cells from 
floxed and WT mice were transferred into lymphopenic Rag2-/- x Il2rg-/- mice 
(where NK cells have been shown to undergo homeostatic proliferation (117) 
followed by tamoxifen treatment (Figure 5.1H-J). In accordance to a previous report 
(61), these data support the role of Eomes and T-bet in repressing and promoting 
TRAIL expression, respectively, and in the maintenance of a mature phenotype. 
Eomes and T-bet are required for the expansion of virus-specific NK cells   
To investigate the effects of Eomes and T-bet on the various stages of the virus-
specific NK cell response we began by inducing the deletion of Eomes or T-bet 
directly before infection. We isolated resting Ly49H+ NK cells from the spleen of 
Eomesf/f x UbCre-ERT2 or Tbx21f/f x UbCre-ERT2 mice (CD45.2) and co-transferred them 
with equal numbers of WT Ly49H+ NK cells (CD45.1) into Ly49h-/- hosts that were 
immediately treated with tamoxifen (or oil as a control). Host mice were then 
infected with MCMV four days post-transfer (PT). We found Eomes to be critical 
for the expansion of Ly49H+ NK cells during MCMV infection, with Eomes-deleted 
NK cells exhibiting a marked impairment in expansion compared to WT NK cells 
(Figure 5.2A-B). Current studies exploring the effect of Eomes expression on the 
phenotype of activated NK cells are underway.  
Similar to Eomes deletion, when T-bet was deleted in NK cells from Tbx21f/f 
x UbCre-ERT2 mice, transferred effector and memory Ly49H+ NK cell numbers were  
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Figure 22 
Figure 5.2. T-box transcription factors are necessary for the expansion of 
antigen-specific NK cells. WT (CD45.1) and Eomesf/f UbCre+ (CD45.2, A-B) or T-
betf/f UbCre+ (CD45.2, C-D) NK cells were co-transferred into Ly49h-/- mice and 
treated with tamoxifen or oil at day -4 PI. Mice were infected with MCMV at day 0 PI. 
(A and C) Percentages of Ly49H+ NK cells are shown. (B and D) The relative 
populations are shown for each time point. (E) Assessment of phenotypic markers at 
day 7 PI for the spleen and liver are shown. (F) MFI of KLRG1 staining it day 7 PI in 
the spleen is shown. (G) Ly49H+ NK cells from WT and T-betf/f UbCre+ mice were 
labeled with CTV, transferred into a Ly49h-/- host, and treated with tamoxifen or oil at 
day -4 PI. Mice were infected with MCMV at day 0 PI. Bar graph shows percentages 
of divided and non-divided NK cells at day 4 PI for each group. Data are 
representative of 2-3 experiments with 4-5 mice per condition. * p < 0.05 and ns, not 
significant, paired Student t-test. 
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severely diminished compared to WT controls (Figure 5.2C-D). Unlike T-bet 
deletion in mature NK cells during homeostasis or homeostatic proliferation (Figure 
5.1), virus-specific NK cells lacking T-bet exhibited an increase in the percentage of 
TRAIL+ NK cells and a more immature phenotype (CD27+ CD11b+ KLRG1lo) at 
day 7 PI (Figure 5.2E-F). A similar phenotype was observed at day 28 PI (data not 
shown). When deletion of T-bet was initiated at day 3 PI instead of at day -4, similar 
results were observed (data not shown). These data uncover a novel and stage-
specific role of T-bet on NK cells where T-bet promotes TRAIL expression in 
antigen-inexperienced NK cells but acts to repress TRAIL expression in antigen-
experienced NK cells.  
To determine if deletion of T-bet in NK cells resulted in decreased 
expansion due to a difference in proliferation, we adoptively transferred equal 
numbers of cell trace violet (CTV)-labeled splenic NK cells from WT and Tbx21f/f x 
UbCre-ERT2 mice into Ly49h-/- hosts that were immediately treated with tamoxifen (or 
oil as a control). Host mice were then infected with MCMV four days post-transfer 
(PT). Both WT and T-bet-deficient NK cells proliferated after infection, with the 
WT NK cells undergoing more divisions (Figure 5.2G). Furthermore, when 
compared to their WT counterparts, a greater percentage of T-bet-deleted NK cells 
had not divided in response to MCMV infection, suggesting that T-bet expression in 
mature NK cells is necessary for the execution of a robust proliferation program. 
Altogether, these data highlight a non-redundant role for T-box transcription factors 
during NK cell priming for the robust proliferation and proper maturation of virus-
specific NK cells. 
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IL-12 and STAT4 signals upregulate T-bet in NK cells during MCMV infection 
To gain insight into when T-box transcription factors may be exerting influences on 
the proliferation of virus-specific NK cells, the amount of T-bet and Eomes in 
Ly49H+ NK cells were measured at different time points during MCMV infection. 
We found that T-bet expression is upregulated at day 2 PI and remains high at day 7 
and 42 PI, whereas Eomes expression is largely unchanged immediately following 
MCMV infection (day 2 PI) and is downregulated in effector and memory NK cells 
at day 7 and 42 PI, respectively (Figure 5.3A). The rapid modulation of T-bet levels 
immediately following MCMV infection suggests a role for pro-inflammatory 
cytokine signals in its upregulation. Because IL-12 has been described to upregulate 
T-bet expression in CD8+ T cells (23, 118), we evaluated the expression of T-bet in 
NK cells from WT:Il12rb2-/- bone marrow chimeras infected with MCMV.  In 
contrast to WT NK cells, we found that T-bet levels were not greatly upregulated at 
day 2 and 7 PI in Il12rb2-/- NK cells (Figure 5.3B). Eomes expression in Il12rb2-/- 
NK cells did not differ from WT NK cells at various time points during MCMV 
infection (data not shown).   
Given that IL-12 induces T-bet, we predicted that the signal transducer and 
activator of transcription 4 (STAT4), which acts downstream of the IL-12 receptor, 
may directly regulate T-bet levels in activated NK cells. Analysis of the Tbx21 
promoter revealed several putative STAT4 binding sites (Figure 5.3C), one of which 
(site 2) is embedded within a conserved noncoding site (CNS). We performed 
STAT4 chromatin immunoprecipitation (ChIP) on resting and IL-12/IL-18-activated  
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Figure 23 
Figure 5.3. IL-12 and STAT4 signals upregulate T-bet expression in NK cells 
during MCMV infection. (A) WT NK cells were transferred into Ly49h-/- mice and 
infected with MCMV. Expression of T-bet and Eomes at the indicated time points is 
shown. (B) Expression of T-bet in WT:Il12rb2-/- bone marrow chimeras is shown for 
the indicated time points. (C) Vista browser image of mouse Tbx21 promoter showing 
CNS regions (gray shading) and three predicted STAT4 binding sites. (D) STAT4 
binding at Tbx21, Ifng, and control promoters as assessed through ChIP followed by 
qPCR in purified WT NK cells stimulated for 18h with IL-12 and IL-18. STAT4 
occupancy as percent of input is shown for target (Tbx21) and control DNA (negative 
control: average of gene desert 50 kb upstream of Foxp3, Utf1, and Zfp42 promoters; 
positive control: Ifng promoter). Data is representative of at least three experiments 
with at least 3 mice per condition. 
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NK cells, and found substantial enrichment of STAT4 binding at site 2 (Figure 
5.3D), ~11 Kb upstream of the Tbx21 transcriptional start site. Thus, these data 
support the direct regulation of T-bet expression in NK cells by IL-12 signaling and 
STAT4 activity during MCMV infection.  
 
T-bet, but not Eomes, is required for the maintenance of virus-specific memory 
NK cells 
We next sought to evaluate the role of Eomes and T-bet on the maintenance of 
memory NK cells following MCMV infection. We isolated NK cells from the 
spleen of Eomesf/f x UbCre-ERT2 or Tbx21f/f x UbCre-ERT2 mice (CD45.2) and co-
transferred them with equal numbers of WT NK cells (CD45.1) into Ly49h-/- hosts 
that were immediately infected with MCMV. At 3 weeks PI, we administered 
tamoxifen to induce gene deletion. Control mice received oil alone. Given the 
downregulation of Eomes expression in virus-specific memory NK cells (Figure 
5.3A), we were not surprised to find that the ratio of Eomes-deleted to WT NK cells 
did not change for several weeks after tamoxifen administration (Figure 5.4A).  
In contrast to Eomes ablation, induced deletion of T-bet in memory NK cells 
led to a significant 3 to 4-fold decrease in the ratio of T-bet-deleted to WT cells in 
mice receiving tamoxifen compared with those receiving oil alone as a control 
(Figure 5.4B), suggesting a role for T-bet in the persistence of virus-specific 
memory NK cells. Although no changes were observed in the frequency of TRAIL-
expressing or CD27+ CD11b+ NK cells (Figure 5.4C), a significant decrease in the 
expression of KLRG1 was observed (Figure 5.4D). Altogether, these data uncover a  
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Figure 24 
Figure 5.4. T-bet, but not Eomes, is required for the maintenance of memory NK 
cells. WT (CD45.1) and Eomesf/f UbCre+ (CD45.2, A) or T-betf/f UbCre+ (CD45.2, B-
D) NK cells were co-transferred into Ly49h-/- mice. Mice were infected with MCMV 
and treated with tamoxifen or oil at day 28s (A) or 19 (B-D) PI. (A) The relative fold 
change of floxed and WT populations relative to their starting ratio is shown. (B) The 
ratio of floxed to WT populations in mice receiving oil versus tamoxifen at day 32 PI 
is shown. Assessment of phenotypic markers for the spleen and liver (C and D) are 
shown. Data is representative of at least three experiments with 4-5 mice per 
condition. * p < 0.05 and ns, not significant, paired Student t-test. 
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unique role for T-bet in the maintenance of number and phenotype of virus-specific 
memory NK cells, further highlighting the stage-specific function of these T-box 
family transcription factors. 
 
Discussion 
Our understanding of the transcriptional regulation of NK cell development and 
function has increased during the past decade (119, 120). However, the exact role 
many of these transcription factors play during the antiviral response of NK cells is 
largely unknown. T-box family transcription factors Eomes and T-bet have 
overlapping and distinct effects on NK cell maturity and function. Eomes and T-bet 
were previously shown to play a redundant role in the induction of CD122, the 
receptor that mediates IL-15 signaling and promotes the survival and homeostasis of 
NK cells and memory T cells (58). During NK cell development, Eomes has been 
described to support NK cell maturation past the DX5+ stage, a step that is 
characterized by acquisition of a full Ly49 repertoire (61). T-bet appears to direct 
the development of Eomes- NK cells in the liver (62), and TRAIL+ NK cells (61, 
121). Although the importance of T-bet and Eomes in NK cell development has 
been investigated, their influence on the antigen-specific NK cell response has not 
been characterized. Using an inducible deletion system, we have evidence to 
support a stage-specific and non-redundant role for T-box transcription factors 
during NK cell homeostasis, homeostatic proliferation, antiviral response, and 
generation of long-lived memory.  
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Deletion of Eomes or T-bet before or early during infection led to a 
significant decrease in the expansion of Eomesf/f x UbCre-ERT2 or Tbx21f/f x UbCre-ERT2 
NK cells relative to WT. This could be due to possible complementary actions of 
Eomes and T-bet on the promotion of a proliferative program following infection. 
T-bet-deficient NK cells exhibited a defect in proliferation following MCMV 
infection, thus highlighting the importance of this transcription factor on the 
execution of a robust proliferative program. Studies exploring the effect Eomes 
expression has on NK cell proliferation are currently underway.  
We found the expression of TRAIL to be more fluid than previously 
thought. Despite TRAIL+ DX5- NK cells being described to originate in the fetal 
liver (122), we found deletion of T-bet early during MCMV infection resulted in an 
increased frequency of TRAIL+ NK cells.  This increase in the TRAIL+ population 
was accompanied by a decrease in maturity (higher percentages of CD27+ x CD11b+ 
cells and less KLRG1 expression). This reliance on T-bet for the maintenance of a 
mature phenotype was also observed following the deletion of T-bet in memory NK 
cells. Previous reports have described T-bet as an important factor in the terminal 
maturation of NK cells (60). Our data suggest that T-bet is needed continuously for 
the maintenance of a mature phenotype.  
Although Eomes and T-bet may have complementary functions in the 
induction of a proliferative program in response to infection, T-bet acts to maintain 
antigen-experienced NK cells in a mature state. Current studies exploring the effect 
of Eomes expression on the phenotype of activated NK cells are underway.  We 
propose that in addition to TRAIL marking the distinction of immature NK cells 
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(61, 122) and a possibly distinct NK cell lineage in the liver (62), it may also mark a 
more immature population, as loss of TRAIL+ was accompanied with increased 
KLRG1 expression. Interestingly, deletion of T-bet at a memory time point skewed 
a previously equal WT: Tbx21f/f x UbCre-ERT2 population in favor of WT, suggesting 
that T-bet may be necessary in the maintenance of memory NK cells. This finding 
could signify a stage-specific effect for T-bet where it functions to maintain TRAIL 
expression and a mature phenotype in naïve NK cells but promotes persistence and 
maturity, repressing TRAIL expression, in virus activated antigen experienced NK 
cells.  Future studies will address the effect loss of T-bet and Eomes may have on 
recall responses.  
The impact of Eomes and T-bet in antigen-experienced NK cells at various 
stages during viral infection highlights the continuous importance of these 
transcription factors throughout the lifespan of NK cells. Future studies will 
investigate the specific gene targets of Eomes and T-bet in resting, activated, and 
memory NK cells, in order to further understand their distinct or complementary 
activity during the antiviral NK cell response. Our current findings reveal distinct 
molecular events that control virus-specific NK cell responses, and may inform 
clinical approaches that couple NK cell-mediated immunity to the treatment of 
human diseases. 
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Materials and Methods 
Mice, tamoxifen treatment, and infections 
All of the mice used in this study were bred and maintained at MSKCC in 
accordance with IACUC guidelines. Mixed bone marrow chimeric mice were 
generated and adoptive transfer studies were performed as previously described 
(13). Mice were infected by intraperitoneal (IP) injections of MCMV (Smith strain) 
with 7.5  ×  103 plaque-forming units.  Mice were administered 8 mg tamoxifen 
dissolved in 200 µL olive oil by oral gavage following a day 0, 1, 3 regimen. 
Control mice received 200 µL olive oil. 
 
Flow cytometry and cell sorting 
Fc receptors were blocked with 2.4G2 mAb before staining with the indicated 
surface or intracellular antibodies (BD, BioLegend, or eBioscience). Flow 
cytometry was performed on an LSR II (BD). Cell sorting was performed on an 
Aria II cytometer (BD). All data were analyzed with FlowJo software (TreeStar). 
NK cell enrichment and adoptive transfers were performed as previously described 
(91).   
 
qRT-PCR and ChIP 
Quantitative reverse-transcription PCR and chromatin immunoprecipitation (ChIP) 
were performed as described previously (92). The following qPCR primers were 
used for ChIP studies: CNS1 pTbx21, For: 5’- CTAAGCAGGCACTCCATCAGTTG 
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-3’, Rev: 5’- GTCCTTCCTCCGCTGTTCTATTC -3’; CNS2 pTbx21, For: 5’- 
TAGCGGAAAGCGAGATGGTG -3’, Rev: 5’- 
AGTGAAGGAGTTCTGTGGTTCTGG -3’; CNS3 pTbx21, For: 5’- 
GAGCCGACATACTGACATTCTGC -3’, Rev: 5’- 
CATTCTCCTCTCCCACCATCTTG -3’;  Ifng promoter, For: 5’-
GCTCTGTGGATGAGAAAT-3’, Rev: 5’-GCTCTGTGGATGAGAAAT-3’; Gene 
desert 50 kB upstream of Foxp3, For: 5’-TAGCCAGAAGCTGGAAAGAAGCCA-3’, 
Rev: 5’-TGATACCCTCCAGGTCCAACCATT-3’; Utf1, For: 5’-
AGTCGTTGAATACCGCGTTGCTG-3’, Rev: 5’-
CTGTTGAGATGTCGCCCAAGTGC-3’; Zpf42, For: 5’-
AGAGGGCGGTGTGTACTGTGGTG-3’, Rev: 5’-
CTTCTTCTTGCACCCGGCTTGAG-3’. 
Statistical methods 
All plots depict mean ± s.e.m. Two-tailed unpaired Student’s t-test was used to 
derive statistical differences. A p value > 0.05 was considered significant. Plots and 
statistical analyses were produced in GraphPad Prism. 
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CHAPTER 6 
CONCLUSION 
Traditionally classified as a member of the innate immune response, NK 
cells continue to challenge the conceptual boundaries delineating the innate and 
adaptive immune compartments. Although immunological memory has been a 
defining pillar for cells of the adaptive immune response, recent work has 
uncovered this characteristic in NK cells. NK cells are able to respond to certain 
small molecules and viruses in an antigen-specific manner, and mount an enhanced 
response upon antigen reencounter. Because the precise signals governing NK cell 
“memory” were largely undefined, this thesis work explored the role of pro-
inflammatory cytokines IL-12, IL-18, and type I IFN, and T-box transcription 
factors, T-bet and Eomes, on the generation of a long-lived anti-viral NK cell 
response.  
Similar to the need for “Signal 3” by CD8+ T cells, NK cells can now be 
appreciated to rely on pro-inflammatory cytokine signals for a productive antiviral 
response. The intricate details of “Signal 3” for NK cells are summarized in Figure 
6.1. In conjunction with Ly49H engagement and costimulation through CD28 
triggering, IL-12 signaling leads to the activation and dimerization of STAT4, 
which translocates into the nucleus to promote IFN-γ production and the 
proliferation of Ly49H-bearing NK cells.  The nuclear translocation of activated 
STAT4 dimers also leads to the increase in expression of MyD88 and T-bet. 
Increased levels of Myd88 potentiate IL-18 signaling, and result in increased IFN-γ  
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Figure 25 
Figure 6.1. Pro-inflammatory cytokine and transcription factor control of the 
anti-viral NK cell response. In conjunction with Ly49H engagement and 
costimulation through CD28 triggering, (A) IL-12 signaling leads to the activation and 
dimerization of STAT4, which translocate into the nucleus to increase proliferation, 
IFN-γ production, and the expression Myd88 and T-bet. (B) Increase of Myd88 
potentiates IL-18 signaling, and results in increased IFN-γ production and 
proliferation. (C) T-bet and its close family member, Eomes, act in a non-redundant 
fashion to promote the anti-viral proliferative program. Constant T-bet expression is 
necessary at all stages of the activated NK cell’s lifecycle to maintain a mature 
phenotypic program, as well as in memory NK cells to promote cellular persistence. 
(D) Lastly, type I IFN signaling acts to protect the antiviral NK cell response from 
NKG2D-mediated apoptosis by inhibiting the upregulation of NKG2D-ligand 
expression.  
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production. T-bet and its close family member, Eomes, act in a non-redundant 
fashion to promote the anti-viral proliferative program. Furthermore, constant T-bet 
expression is necessary at all stages of the NK cell response to maintain a mature 
phenotypic program, as well as in memory NK cells to promote cellular survival. 
Lastly, type I IFN signaling acts to protect the antiviral NK cell response from 
NKG2D-mediated apoptosis. All of these events act in concert to promote the long-
lived antiviral NK cell response. These findings further our understanding of the 
complex network of pro-inflammatory cytokine signaling on the different stages of 
the NK cell response. The capability of an NK cell to kill a susceptible target 
without prior sensitization, in addition to their role in the control of viral infections, 
has made this cell an attractive target in vaccine strategies and anti-tumor 
immunotherapy. Incorporation of pro-inflammatory cytokine treatment, or targeting 
of transcription factors in NK cells, can be beneficial in harnessing NK cell function 
for therapeutic purposes.   
Pro-inflammatory cytokines act on NK cells to mediate an effect on the 
shaping of the immune response, creating a bridge that functionally connects innate 
immunity and adaptive immunity. NK cells and dendritic cells (DC) are known to 
extensively cross-talk (123, 124), with pro-inflammatory cytokines mediating a 
significant role in this NK-DC communication. This thesis work elaborates on the 
DC-derived pro-inflammatory cytokines that shape the NK response. Reciprocally, 
NK cells promote DC maturation and participate in the maturation of DCs (124). It 
has been shown that NK cell-mediated DC maturation is dependent on pro-
inflammatory cytokines IL-12 (125), IL-18 (126), and type I IFN (127). NK cells 
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“edit” mature DC populations through direct killing of immature DCs (127-129). 
This form of DC “editing” by NK cells can be seen as a method of “quality control”, 
where only properly activated DC are allowed to migrate to the lymph nodes and 
subsequently activate a productive T cell response. Furthermore, NK cell-mediated 
killing of infected cells provides antigen-presenting cells, like the DC, with the 
apoptotic bodies necessary to prime a CTL response (127, 129-131).  
The reciprocity of NK-DC interactions has led to the direct targeting of NK 
cells in DC-based vaccine strategies (18). Vaccines where DCs are modified to 
express cytokines such as IL-12 with and without IL-15 resulted in the eradication 
of mouse tumors in an NK cell- and T cell-dependent fashion (132-135). 
Furthermore, in a mouse model of neuroblastoma, a fusion vaccine consisting of DC 
and neuroblastoma tumor cells showed a complete protective effect against liver 
metastases in mice that received fused cells transduced to express both IL-12 and 
IL-18 (136). The protective effect of this fusion vaccine was shown to correlate with 
NK cell and T cell activation. Therefore, pro-inflammatory cytokines can be used to 
target the NK cell compartment in the context vaccination. Furthermore, given the 
role of T-bet expression in the maintenance of memory NK cells, targeting 
transcription factors in vaccination strategies may prove fruitful in boosting 
activated NK cell numbers. A combinatorial vaccination approach that incorporates 
the effects of multi-cytokine treatment and transcription factor expression will prove 
paramount to vaccine development. 
Cancer immunotherapy has seen some success with the use of systemic and 
direct-immune cell pro-inflammatory cytokine treatment. However, in the case of 
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systemic cytokine administration, toxicities from the high doses necessary for 
therapeutic effects remain a limiting factor (137). For instance, high dose type I IFN 
administration has been used in the treatment of metastatic malignant melanoma 
with low response rates and high toxicities (138-140). Furthermore, systemic IL-12 
administration can lead to serious hematologic and hepatic toxicities (141). Despite 
these side effects, certain studies show multi-cytokine therapy has the potential to 
increase the positive benefits of NK cell anti-tumor function, while simultaneously 
decreasing toxicity of treatment. Similar to MCMV, where IL-12 potentiates IL-18 
signaling through the increase of MyD88 (Chapter 3), in vivo anti-tumor cytokine 
treatments have suggested inter-cytokine pathway modulation. In a mouse model of 
malignant melanoma, pretreatment with IL-12, followed by low dose type I IFN, 
significantly increased survival of tumor-bearing mice (142). IL-12 pre-treatment 
sensitized tumors and host immune effector cells to low dose type I IFN 
administration through the increase of STAT1, STAT2, and IFN regulatory factor 9 
(IRF9). This effect was mediated by IL-12-elicited IFN-γ production. This study 
identifies an indirect mechanism through which IL-12 modulates another cytokine 
signaling pathway at the level of signal transduction and gene regulation. Multi-
cytokine therapy can also exhibit synergy in promoting anti-tumor effects and NK 
cell activation. In a mouse head and neck cancer model, cytokine gene therapy using 
type I IFN in combination with IL-12 or IL-2 resulted in augmented tumor 
inhibition, and activation of NK cells and CD8+ T cells (143). A greater appreciation 
of cytokine pathways and their potential interactions, direct and indirect, is 
warranted.   
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Direct pro-inflammatory cytokine treatment of NK cells can also harness NK 
cell effector functions towards cancer immunotherapy. Cytokine treatment of mice 
and human naïve NK cells results in a prolonged lifespan and enhanced effector 
functions upon restimulation, features reminiscent of memory (25-27). 
Consequently, cytokine treated NK cells were appropriately termed cytokine-
induced memory-like (CIML) NK cells. Studies in mice have shown CIML NK 
cells are more protective than untreated NK cells against established tumors (26). 
However, the mechanisms through which pro-inflammatory cytokine treatment 
leads to CIML NK cell formation are unknown. Our current work may provide a 
better understanding of the mechanisms through which pro-inflammatory cytokines 
exert their effects on NK cell function. For instance, Chapter 5 describes the ability 
of IL-12 to increase T-bet expression during MCMV infection. Both T-bet and IL-
12 signaling in NK cells leads to increased proliferation and longevity, and IL-12 is 
a commonly used cytokine in the generation of CIML NK cells. Could IL-12-
dependent proliferation and longevity function through a modification of the T-bet 
gene locus that keeps it more accessible to transcription in memory NK cells? 
Furthermore, Chapter 3 describes the stage-specific role of IL-18 on NK cell 
proliferation, where IL-18 is needed for the naïve but not the memory NK cell 
proliferative response. How does IL-18 signaling modify the proliferative pathways 
of an activated NK cell? Can the epigenetic landscape of naïve and memory/CIML 
NK cells explain differences in phenotype and function? Further investigation of 
these cytokine and transcription factor effects on CIML NK cells may prove key in 
enhancing NK cell functions and longevity. Moreover, the memory-like qualities of 
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NK cells, such as enhanced effector functions and longevity, are retained by 
daughter cells, suggesting cytokine-induced changes are hereditary.  
Recent studies in humans have described an epigenetic repatterning in 
adaptive or “memory” NK cell population associated with HCMV seropositivity and 
latent HCMV reactivation (144-146). Epigenetic diversification of adaptive NK 
cells correlated with genome-wide DNA methylation repatterning, which shared 
ample similarity with cytotoxic T cells but differed from canonical NK cells (145).  
These epigenetically unique adaptive NK cells also possessed distinct functionalities 
when compared to canonical NK cells, thus suggesting epigenetic diversification as 
a mechanism in the generation of a memory-like NK cell pool. Although these 
studies failed to investigate the precise signals that led to epigenetic repatterning, 
knowing the heritable and likely epigenetic changes induced by cytokine treatment 
will be of importance to the advancement of NK cell immunotherapy. Enhanced 
molecular approaches will be necessary to decipher the changes endured at the gene 
expression level that lead to a memory NK cell.  
NK cells also mediate antibody-dependent cellular cytotoxicity (ADCC) 
through the recognition of antibody-coated targets by the activating receptor, CD16 
(Fcγ RIIIa) (147, 148). ADCC accounts for an important part of the efficacy shown 
by Rituximab (anti-CD20, non-Hodgkin’s lymphoma) and Herceptin (anti-HER2, 
metastatic breast cancer and gastric carcinoma) treatment of patients (149, 150). 
Cytokine treatment can increase ADCC. IL-12, IL-18, IL-2 and IL-21 are 
documented to increase ADCC in combination with specific antibodies (151, 152). 
Furthermore, type I IFN is implicated in promoting Rituximab-mediated ADCC in a 
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model using IL-15 and CpG ODN A stimulation of PBMC (153). CpG ODN A is a 
potent inducer of type I IFN (154); therefore, the direct function of type I IFN on 
ADCC warrants investigation. In addition to cytokine treatment, co-stimulatory 
receptor triggering has been shown to increase NK cell-mediated ADCC. NK cells 
stimulated by anti-4-1BB antibodies regressed subcutaneous lymphoma tumors in 
mice receiving treatment with Rituxumab (155). Eomes has been shown to be 
required for 4-1BB-mediated antitumor effects (156), which suggests that co-
stimulation pathways in NK cells may utilize members of the T-box transcription 
factor family to mediate their function. The effects of co-stimulation in NK cells are 
not well known, however, the role of T-box transcription factors in mediating 
costimulatory molecule-induced or ADCC-mediated effector functions remains of 
interest.   
Antibody-cytokine fusion proteins, referred to as immunocytokines (IC), 
represent a promising way to reap the benefits of cytokine and antibody treatment 
against certain tumors while minimizing cytokine-mediated toxicity. ICs enhance 
cytokine and Fc binding, resulting in greater conjugate formation between the NK 
cell and the antibody-coated tumor cell (157). Improvement of synapse formation 
results in greater NK cell effector functions and anti-tumor effect, when compared 
to the separate administration of antibody with equivalents amount of cytokines 
(150, 157). ICs have the potential to improve the therapeutic index of cytokines by 
concentrating their function at the site of localized or disseminated disease, thus 
reducing unwanted side effects often associated with systemic cytokine 
administration. 
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Although pro-inflammatory cytokine treatment of NK cells results in the 
activation, proliferation, and attainment of effector function, the trafficking of NK 
cells to a desired location remains an issue. Localized cytokine function, such as 
with the use IC treatments, can circumvent difficulties in targeting activated NK 
cells to the area of need (tumor or infection). Exploring the effect of cytokines or 
transcription factors on the expression of NK cell trafficking receptors, like that of 
IL-18 on CCR7 expression in human NK cells (49) or T-bet on S1P5 expression in 
mouse NK cells (158), may help improve the efficacy of NK cell use in therapeutic 
strategies.  
Attaining a better understanding of what molecular signals execute specific 
NK cell functions is paramount to our ability to harness their actions for therapeutic 
purposes. Pro-inflammatory cytokines IL-12, IL-18, and type I IFN, and 
transcription factors, T-bet and Eomes, affect multiple aspects of the immune 
response. This thesis work expands our understanding of the complex network of 
pro-inflammatory cytokine signaling on the different stages of the NK cell response. 
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APPENDIX 1 
SUPPLEMENTARY FIGURES FOR CHAPTER 3 
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Supplementary Figure 3.1. IL-18R-deficient NK cells exhibit expansion defect 
following MCMV infection. (A) 106 WT (CD45.1) and Il18r1-/- (CD45.2) NK cells 
were co-transferred into Ly49H-deficient mice (CD45.2) and infected with MCMV. 
Plots are gated on total NK cells and the percentages of Ly49H+ NK cells are shown 
for each time point PI. (B) WT (CD45.1) and Il18r1-/- (CD45.2) mixed bone marrow 
chimeric mice were infected with MCMV and percentages of splenic NK cells are 
shown (gated on TCR-β- NK1.1+) for uninfected and day 7 PI. Expression of (C) 
CD69, CD25 at day 1.5 PI and (D) CD11b, KLRG1, and CD90.2 at day 7 PI are 
shown for wildtype and Il18r1-/- Ly49H+ NK cells (compared to uninfected mice) in 
mixed bone marrow chimeric mice. All data are representative of three experiments 
with 2-3 mice per time point. (E) Day 7 splenocytes were incubated with FLICA® 
FAM-VAD-FMK and percentages of Ly49H+ FLICA+ NK cells are shown.  
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Figure 26 
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Figure 27 
Supplementary Figure 3.2. NK cell expansion and memory formation are 
independent of IL-1 during MCMV infection. (A) Wildtype (CD45.1+) and Il1r-/- 
(CD45.2+) mixed bone marrow chimeric mice were infected with MCMV and 
percentages of splenic NK cells are shown (gated on TCR-β- NK1.1+) for uninfected 
mice and at day 7 post-infection. (B) Percentages of IFN-γ+ wildtype and Il1r-/- NK 
cells are shown at day 0 and 1.5 PI. (C) Expression of CD27, KLRG1, and CD90.2 are 
shown for wildtype and Il1r-/- Ly49H+ NK cells (compared to uninfected mice) at day 
7 PI. All data are representative of two independent experiments with 3-4 mice per 
time point.  
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